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 ABSTRACT  
 




The development of a multicellular organism from an embryo is one of the 
nature’s most remarkable phenomena. Deciphering how this transformation 
occurs is a fundamental challenge in biology with profound biomedical 
implications. Insights into the molecular signals guiding developmental patterning 
may provide design strategies to promote multicellular structure formation in 
applications such as tissue engineering and regenerative medicine.  In this thesis, 
we explored the applications of controllable gene expression techniques in 
combination with engineering strategies in regulation and patterning of cell 
differentiation and pluripotency, by pursuing three related research projects:  
 
1. Reversible immortalization of cardiomyocytes to enable their proliferation 
necessary for obtaining large cell numbers 
2. Patterning of the delivery of Doxycycline (Dox), the expression modulator 
of inducible BMP-2 expression vector, to mesenchymal stem cells cultured 





3. Patterning of the Nanog gene expression in embryonic stem cells, using a 
microfluidic device, to establish differentiation – pluripotency boundaries 
that mimic the developmental processes in vivo. 
 
In the first project, we developed a novel strategy for controlled expansion of 
non-proliferating primary neonatal rat cardiomyocytes by lentivector-mediated 
cell immortalization, and then the reversal of the phenotype of expanded cells 
back to the cardiomyocytes state.  Primary rat cardiomyocytes were transduced 
with simian virus 40 large T antigen (TAg), or with Bmi-1 followed by the human 
telomerase reverse transcriptase (hTERT) gene; the cells were expanded; and 
the transduced genes were removed by adenoviral vector expressing Cre 
recombinase. The TAg gene was more efficient in cell transduction than the Bmi-
1/hTERT gene, based on the rate of cell proliferation. Immortalized cells 
exhibited the morphological features of dedifferentiation (increased vimentin 
expression, and reduced expression of troponin I and Nkx2.5) along with the 
continued expression of cardiac markers (α-actin, connexin-43, and calcium 
transients). After the immortalization was reversed, cells returned to their 
differentiated state, as evidenced by molecular and functional properties inherent 
to terminally differentiated cardiomyocytes. This strategy for controlled expansion 
of primary cardiomyocytes by reversible gene transfer could provide large 
amounts of a patient's own cardiomyocytes for cell therapy, and enable 






In the second project, we developed a novel patterning strategy by using 
inducible gene expression systems in conjunction with simple multi-laminar fluidic 
techniques, which can directly pattern the expression of particular gene at 
transcriptional level. Using osteogenic differentiation of human mesenchymal 
stem cells as a model, we describe a novel approach to spatially regulate the 
expression and secretion of bone morphogenetic protein (BMP-2) in a two-
dimensional field of cultured cells, by flow patterning the modulators of inducible 
BMP-2 gene expression. We first demonstrated a control of gene expression, 
and control of osteogenic differentiation of the cell line with inducible expression 
of BMP-2. Then we designed laminar flow systems, with patterned delivery of 
Doxycycline (Dox), the expression modulator of inducible BMP-2 expression 
vector. The patterned concentration profiles were verified by computational 
simulation and dye separation experiments. Experiments conducted in the flow 
systems for a period of three weeks showed the Dox concentration dependent 
osteogenic differentiation, as evidenced by mineral deposition. This strategy 
combining inducible gene expression with laminar flow technologies provides an 
innovative way to engineer tissue interfaces.  
 
In the third project, we further developed the patterning strategy for gene 
expression to form boundaries of different gene expression domains in cultures 
of mouse embryonic stem cells. Using Nanog safeguarded embryonic 
pluripotency as a model; we demonstrated controlled Nanog expression, which 





small molecules, as evidenced by alkaline phosphatase (AP) staining, 
immunofluorescent staining, and gene expression analysis.  By patterning Nanog 
gene expression, as well as soluble factors in the laminar fluidic system, we 
successfully developed varied differentiation – pluripotency boundaries between 
Nanog expressing pluripotency zones and Nanog suppressed early 
differentiation zones from the same population of cells, which mimic the 
development process in vivo. Mechanistic insights can be gained on dissecting 
the signaling pathways that drive multicellular patterning during the natural 
processes of embryonic and adult development. 
 
In summary, we demonstrated that controlled expansion of non-proliferating 
primary cells can achieved by reversible genetic manipulation, and that varied 
continuous, graded pluripotency – differentiation boundaries can established by 
patterning the expression of target genes via a simple laminar fluidic system. 
Taken together, these approaches provide innovative models to modulate cell 
function at the transcriptional level.   
 
Additional cooperative research was conducted during my graduate training. The 
manuscript of this study “Micropatterned Mammalian Cells Exhibit Phenotype-
Specific Left-Right Asymmetry” was submitted to Proc Natl Acad Sci U S A., and 
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Figure 2.4  Cell morphology (A) TAg-transduced cells on day 7. (B) TAg 
clone 8 cells. (C) Bmi-1/hTERT-transduced cells on day 13. (D) Bmi-
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duration). EEEEEEEEEEEEEEEEEEEEEEEEEEE.72 
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cells were troponin (FITC) positive and vimentin (PE or Texas red) 
negative. (C) Primary cardiomyocytes transduced with lentiviral vector 
expressing GFP (MOI, 2). Scale bar: 50 mmEEEEEEEEEEEE.79 
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was monitored by measuring total DNA quantification. Cell culture medium 
was DMEM supplemented with 10% FBS, 10mM HEPES, 2mM L-
glutamine, and penicillin–streptomycin (100U/ml)EEEEEEEEEE.79 
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patterned osteogenic differentiation. (B) Flow channel (main channel: 20 
mm L × 6 mm W × 0.1 mm H)EEEEEEEEEEEEEEEEEE..88 
Figure 3.3  Characterization of inducible BMP-2 expressing cell line (C9) 
(A) ELISA measurement of the secreted BMP-2 in culture media (n = 3). 
(B) C9 cell proliferation profile by DNA measurement (n = 6). (C) 
Measurement of Calcium deposition (n = 4). (D) Measurement of alkaline 
phosphates (AP) (n = 4). *: p < 0.05. **: p < 0.05. (E) von Kossa staining of 
the C9 cells. (F) AP staining of the C9 cells. Original magnification: 200×. 
Scale bar: 1 mmEEEEEEEEEEEEEEEEEEEEEEEE..98 
Figure 3.4  Flow analysis Simplified flow model, the steady-state velocity and 
concentration profiles are shown for a flow rate of 1 µl min−1 × 2. Data 
were calculated for the diffusion coefficient DDox = 3.93 × 10
−6 cm2 s−1, 
fluid viscosity ν = 10−3 Pa s, fluid density ρ = 103 kg m−3, and inlet 
concentrations CDox = 1 ng ml
−1 = 2.25 × 10−12 mol ml−1 and CDox = 0 ng 
ml−1EEEEEEEEEEEEEEEEEEEEEEEEEEEEE.100 
Figure 3.5 Dye separation studies Separation of Calcein stain in the flow 
channel at the flow rates of 5 µl min−1 × 2 (A) and 1 µl min−1 × 2 (B). Data 
are for the diffusion coefficient of Calcein DCalcein = 2.6 × 10
−6 cm2 s−1, and 
inlet concentrations of Calcein C+ = 2 µM and C− = 0, diffusion coefficient 
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of Trypan blue of DTrypan blue = 2.21 × 10
−6 cm2 s−1, and input 
concentrations of Trypan blue of C+ = 229 µM and C− = 0. Flow direction is 
left to right. Original magnification: 100×. Scale bar: 1 mmEEEEE...101 
Figure 3.6  Dox dependent osteogenic differentiation in the flow channel. 
C9 cells were cultured in osteogenic differentiation medium in a perfused 
flow channel, at a flow rate of 1 µl min−1 × 2, for 3 weeks. Images show 
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Perfusion medium with Dox 1 ng ml−1 (top)/1 ng ml−1 (bottom); (B1, B2) 
Perfusion medium: Dox 0 ng ml−1 (top)/1 ng ml−1 (bottom); (C1, C2) 
Perfusion medium: Dox 0 ng ml−1 (top)/0 ng ml−1 (bottom). (A3, B3, C3) 
Intensity of calcium staining, obtained by pooling repeated experiments (n 
= 3 per condition). The staining of the deposited calcium is expressed at 
the ratio of the normalized sum of segmented ( 0.25 mm) image intensity 
and the minimum intensity along the y axis (the width) of the chamber. 
Data were processed using Matlab R2007 program. Flow direction: left to 
right. Scale bar: 1 mmEEEEEEEEEEEEEEEEEEEEE.103 
Supplemental figure 3.1  Flow chamber The flow chamber consisted of a 1mm 
thick borosilicate glass plate glued into the bottom of a uniformly deep 
groove milled into a Plexiglas block, and another glass slide with pre-
seeded cells. The two plates were held together with screws and a 
Plexiglas lid, separated by a uniform thickness rectangular silastic spacer 
(McMaster). As a result, a flow chamber (5.2 cm long x 1.2cm wide x 
154>m high) was created. Flow inlets and outlets were connected to 
cylindrical reservoirs in the Plexiglas block. A 2mm thick borosilicate glass 
blocked each of the cylindrical reservoirs in the middle, and separated the 
flows to and from the two ports. Plastic tubing (high-temperature silicone 
rubber soft tubing, 1.59mm ID, 3.18mm OD, McMaster) connected the 
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Supplemental figure 3.2  Characterization of flow chamber (A) Simplified 
flow models, the steady-state velocity and concentration profiles are 
shown for the flow channel at flow rate of 4µl/min x2. Data were calculated 
for the diffusion coefficient DDox=3.93x10
-6cm2/s, fluid viscosity ν=10-3Pa*s, 
fluid density ρ=103kg/m3, and inlet concentrations CDox=1ng/ml= 2.25x10
-
12mol/ml and CDox=0ng/ml=0. (B) Separation of Calcein stain in the flow 
channel at the flow rates of 4µl/min x2. Data are for the diffusion 
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Supplemental figure 3.3  Dox dependent osteogenic differentiation in flow 
chamber C9 cells were cultured in osteogenic differentiation medium in a 
perfused flow chamber, at a flow rate of 4µl/min x2, for 3 weeks. Images 
show von Kossa staining of calcium deposition for selected conditions: 
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Chapter 1  Introduction 
 
1.1  Temporal and spatial regulation of gene expression and the related 
cell function during in vivo development 
The transformation of a single pluripotent cell into a multi-cellular organism in 
vivo involves a multitude of interrelated and orchestrated intercellular and 
intracellular processes that guide tissue morphogenesis. The most critical 
phenomenon in tissue morphogenesis is the spatial-temporal organization of cell 
differentiation from which the proper tissue functions arise.  
 
1.1.1  Controlled expression of morphogens 
Over the past few decades, evidences accumulated to support the existence of 
morphogen gradients acting as graded positional cues to control cell fate 
specification in developing tissue (Gurdon and Bourillot 2001; Tabata and Takei, 
2004). It is generally proposed that a signal produced from a defined localized 
source forms a concentration gradient as it spreads through surrounding tissue. 
The graded signal then acts directly on cells, in a concentration-dependent 
manner, to specify gene expression changes and cell fate selection. The first 
molecular demonstration of the gradients specifying distinct cell fates is 
transcription factor Bicoid in the Drosophila syncytium (Driever and Nüsslein-
Volhard, 1988a, 1988b), shown to be distributed along a gradient expanding from 
the anterior pole to more than one-half of the embryo and to regulate the 





as Dpp, Wingless, Spitz, Hedgehog, Activin and Nodal have been described as 
morphogens in a wide variety of organisms (Martinez Arias, 2003; Tabata and 
Takei, 2004; Schier and Talbot, 2005; Affolter and Basler, 2007). Drosophila 
embryo was used as a development model, to determine how the distribution of 
morphogens through a tissue establishes and maintains a gradient of activity, 
and how the signal is perceived and interpreted in a graded manner by the 
receiving cells (Ashe and Briscoe, 2006) (Figure 1.1). 
 
 
Figure 1.1 Patterns of morphogen gradients in developing tissues (A) A gradient of a 
signaling molecule (blue) within tissue (grey cells) provides positional information, instructing 
cells to adopt distinct cell fates (colored cells), according to the concentration of signal to 
which they are exposed. (B) The graded distribution of the transcription factor Bicoid 
establishes anteroposterior polarity in the developing Drosophila embryo. Immunostaining 
reveals the gradient of Bicoid distribution in the embryo. Expression of orthodenticle and 
hunchback genes is induced by high and low levels of Bicoid, respectively. (C) The 
dorsoventral (DV) axis of the early Drosophila embryo is patterned by graded Dorsal (Dl) 
activity (left). The ligand Spatzle binding to its transmembrane (TM) receptor Toll initiates 
signal transduction that, through the action of the kinase Pelle, activates the NF-B-like 
transcription factor Dl. (Right) Graded distribution of Dl protein; twist and rhomboid are 






The common controlled signaling pathways associated simple topobiological 
transformations (Figure 1.2) are briefly described here illustrating the controlled 
gene expression in vertebrate development process.  
 
Stratification: Stratification is a process that enables the epithelium to form a 
multilayered barrier, protecting the organism from its environment, and allows 
functional diversification. During stratification, the daughter cells remaining in the 
basal layer can still proliferate, while the other daughter cells, become postmitotic, 
and start to pile up, forming multiple layers. Controlled activation of the p63 
pathway in early epidermal lineage when cells are still forming a single layer 
(Green et al., 2003; Koster et al., 2004) is required in the stratification process 
(Koster and Roop, 2004).  
 
Convergent extension: Convergent extension allows a change of shape of 
epithelial sheets by cell rearrangements. Lateral and medial cells become 
polarized and then the lateral cells intercalate between the medial cells, causing 
an extension along the anteroposterior axis (Keller, 2002). It is a fundamental 
topobiological transformation process involved in multiple organ formations, for 
example the formation of the avian primitive streak (Wei and Mikawa, 2000), and 
shaping of the avian neural plate (Schoenwolf, 1991; Schoenwolf and Alvarez, 
1989), with the involvement of noncanonical Wnt signaling (Keller, 2002). 
 
Invagination: Invagination of epithelial tissues is seen in the organization of the 





critical role in tooth formation (Jernvall and Thesleff, 2000). The activation of 
Wnt/β-catenin and the suppression of BMP by noggin lead to invagination of the 
epithelial placode to initiate hair follicle formation (Jamora et al., 2003). 
 
 
Figure 1.2  Topobiological transformation events during epithelial organ 
formation. These events are meaningful only at the level of cell groups (epithelial sheet, 
mesenchymal condensations), not at the single cell level.  
 
1.1.2  Gene regulatory networks 
Although the paradigm of morphogen patterning is widely accepted, recent 
developmental studies, in particularly of the relative sizes and positions of target 
gene domains and of the dynamic activation of morphogen target genes during 
development, added complexity into the model of morphogen activity.  
 
Gene regulatory networks (GRNs) have been developed to study the spatial-
temporal dynamics of controlled development process at the most fundamental 
level. The gene regulatory networks contain two complementary components. 
One component is the regulatory gene itself, such as a transcription factor or a 
signaling molecule. Transcription factors bind to specific sequences in the DNA 
and activate or repress the transcription of a gene or a group of genes. Signaling 





activation of certain transcription factors in the cells that receive the signal. The 
complementary part of the regulatory apparatus is the regulatory genome. Every 
gene contains regulatory sequences that control when and where it is expressed.   
 
Specification is the process by which cells acquire identities or fates that they 
and their progeny will adopt. To reach a given specification state the cells go 
through various regulatory states and one leads to the next. An initial set of 
transcription factors together with signaling cues from the neighboring cells 
activates a number of regulatory modules, which turn on/off the expression of 
regulatory genes that construct the next regulatory state of the cell until 
specification and differentiation are achieved. These inter-regulating genes form 
a regulatory network that is essentially the genomic program for development. 
 
Here we use the gene regulatory network that governs endomesoderm 
specification in the sea urchin embryo to demonstrate the sophisticated spatial-
temporal regulation of gene expression in development process. Early 
specification of endomesodermal territories in the sea urchin embryo depends on 
a moving torus of regulatory gene expression. This dynamic patterning function is 
encoded in a gene regulatory network (GRN) subcircuit (Figure 1.3) that includes 
the otx, wnt8, and blimp1 genes and other components:  blimp1, the early 
isoform of the blimp1 gene (Livi and Davidson, 2006); nb-TCF, complex of 
nuclear β-catenin and TCF transcription factor; GSK3, enzyme responsible for β-





signal ligand. In the absence of nuclearized β-catenin, a Groucho/TCF complex 
forms instead (Range et al. 2005) and acts as a dominant repressor at both the 
wnt8 and blimp1 loci (dark blue barred stems). nb-TCF is inhibited from forming 
by GSK3, the biochemical mechanism of which is symbolized by the solid circle. 
Positive inputs from Blimp1 and nb-TCF control wnt8 transcription (Minokawa et 
al. 2005), whereas both nb-TCF and Otx are required for blimp1 expression; 
blimp1 is subject to autorepression via two Blimp1 target sites.  
 
Previous studies (Smith et al., 2007) revealed that expression of the blimp1 gene 
begins in the micromeres around 6 hours after fertilization and appears in the 
adjacent tier of mesodermal cells by 12 hours. Soon after, expression disappears 
from the micromeres. By 18 hours, expression of blimp1 begins in the adjacent 
presumptive endoderm lineage and disappears from the mesodermal cells. 
Autorepression of blimp1 accounts for progressive extinction of expression in the 
center of the torus, whereas its outward expansion follows reception of the Wnt8 
ligand by adjacent cells. Thereby, the gene regulatory networks control both the 







Figure 1.3  Moving-torus gene expression pattern (A) Expression pattern of 
blimp1 or wnt8 genes (red). The innermost cells are skeletogenic micromeres; the red 
ring in the second drawing shows mesoderm cells (prospective secondary mesenchyme); 
the outer ring is definitive endoderm. (B) GRN subcircuit including otx, blimp1, and Wnt8 
genes and other components. (C) Expression of wnt8 and blimp1, visualized by Whole 
Mount In-Situ Hybridization (WMISH). By fifth cleavage, wnt8 transcript is evident in the 
four micromeres at the vegetal pole. One cleavage later (sixth), blimp1 transcripts are 
present in the micromeres. After this, wnt8 and blimp1 are expressed in the same 
territories. 
 
1.1.3.  Conclusion 
In summary, the spatial and temporal regulation of genes expression drive the 
processes of cellular differentiation and morphogenesis, leading to the creation of 
different cell types in multicellular organisms where the different types of cells 
may possess different gene expression profiles though they all possess the same 
genome sequence.  An important goal in cell and tissue engineering is to 
recapitulate this spatial and temporal pattern of genes expression, in order to 
engineer cells and tissue that reflect the function and structure derived from 
native development process. Integrative strategies are particularly needed to 
engineer spatial and dynamic distribution of genes / molecules along the tissue. 






1.2  Biological strategies for regulating gene expression  
As we discussed in the previous session, development of a multicellular 
organism requires the integration of multiple events occurring at specific times 
and locations during embryogenesis. Advances in methods for genetic 
engineering in mammals now enable researchers to explicitly examine the 
temporal and spatial role of genes expression during development in vivo and 
further engineer particular gene expression in vitro.  Here we review two 
controlled gene expression systems: reversible gene expression and inducible 
gene expression, which have been used in engineering the dynamics of gene 
expression.    
 
1.2.1  Reversible gene expression 
Conventional genetic engineering uses viral vectors, such as retroviral or 
lentiviral vectors to introduce exogenous genes into cells. The genomic 
integration of viral vectors is of little concern for mechanistic studies of gene 
regulation, but their presence in the genome may result in cellular abnormalities 
in a potential therapeutic setting (Maherali and Hochedlinger 2008; Soldner et al., 
2009). Although the use of transient factor delivery with vectors, which do not 
integrate into the genome, may overcome the problem, the systems suffer from 
very inefficient transduction.  To this end, reversible gene expression strategies 
have been developed, which entails genomic integration of vectors, followed by 






Figure 1.4  Reversible gene expression and transient gene expression systems 
Transposons and loxP-flanked vectors integrate into the host genome and can be 
excised using specific enzymes, whereas episomal vectors and adenoviruses are 
transiently introduced into cells and diluted by cell division. Red boxes, reprogramming 
factors; blue boxes: transposase recognition sites; green rectangles: loxP sites. 
 
The classical expression-excision system uses site-specific recombinases 
derived from bacteriophages and yeast (Branda and Dymecki 2004; Joyner and 
Zervas 2006; Lewandoski 2001). The site-specific recombinases Cre and Flp 
bind to and recombine specific sequences of DNA termed loxP or FRT sites, 
respectively. By flanking essential exons with either loxP or FRT sites particular 
genes can be conditionally inactivated or activated, depending on the structure of 
the genes and exons targeted. In cells containing Cre or Flp and a gene with 
exons flanked by loxP or FRT sites, the gene will be permanently inactivated or 
activated in cells expressing Cre or Flp and their progeny. These techniques 





temporal-spatial pattern of Cre or Flp expression could be determined by the 
gene into which Cre or Flp has been targeted. Particularly, the temporal control 
of Cre and Flp has been enabled by the development of ligand-regulated forms 
of Cre and Flp, such as tamoxifen-inducible CreERT2 and tetracycline-responsive 
Cre lines (Feil et al., 1997; Indra et al., 1999) both systems allow the timing of 
Cre/Flp expression to be tightly regulated. 
 
A potential limitation of this technique is that the Cre-mediated excision leaves 
loxP sites at random locations in the genome, which may disrupt the function and 
expression of endogenous genes. The novel approach has been developed 
based on the piggyBac transposon, a mobile genetic element from insects that 
efficiently integrates into the genome of mammalian cells (Wang et al., 2008). 
Notably, piggyBac transposons can be entirely removed when re-exposed to 
transposase, thereby, both integration and excision are catalyzed by the 
piggyBac transposase, which restores the correct genomic sequence in >90% of 
excision events (Wang et al., 2008). The major advantages of transposon 
mediated gene delivery are high reprogramming efficiency and evidently low 
incidence of genetic alterations. A potential limitation of piggyBac-mediated 
reprogramming is the possibility of 'transient' integration-excision events during 
the two rounds of transposase expression, which might lead to alterations in 







1.2.2 Inducible gene expression 
The development of inducible gene expression system was largely inspired by 
Nature's regulatory mechanisms. Signaling proteins that mediate hormonal 
responses were first adopted as tools for transcriptional control, as it was found 
that the ligand-binding domains of the glucocorticoid, estrogen, and ecdysone 
receptors (GR, ER, and EcR) can be fused to heterologous proteins to modulate 
their function (Christopherson et al., 1992; Eilers et al., 1989;  Green and 
Chambon, 1987). Coupling these ligand-binding domains to DNA-binding and 
transactivating polypeptides therefore enables the small-molecule-dependent 
transcription of genes driven by the corresponding response elements.  Since 
their introduction during the late 1980s, chimeric hormone receptors have been 
widely used to regulate gene expression in cultured cells and embryos (Kolm and 
Sive, 1995; de Graaf et al., 1998, Esengil et al., 2007).  
 
A simple method of transgene regulation was subsequently developed that equip 
the transgene with a known promoter sensitive to a small molecule drug, such 
that gene expression is controlled pharmacologically by administering a small 
molecule drug. The Tet system was the first one described, and has since 
became well established as a research tool. Bacterial resistance to this antibiotic 
involves the expression of a transmembrane efflux pump (TetA), which is 
regulated by a transcriptional repressor (TetR). In the absence of tetracycline, or 
its synthetic derivative doxycycline, TetR binds to operator sequences (tetO) in 





promotes its dissociation from tetO, enabling tetA transcription and antibiotic 
clearance from the bacteria.  
 
Based on this system, Gossen and Bujard established two ligand-inducible gene 
transcription strategies that can be applied in mammals. In the “Tet-Off” system, 
the DNA- and ligand-binding domains of TetR are fused with the VP16 activation 
domain to form a constitutive transcriptional activator (tTA) that is inhibited by 
tetracycline (Gossen and Bujard, 1992). The “Tet-On” system utilizes a “reverse” 
form of tTA (rtTA) that actually requires tetracycline for tetO binding (Gossen 
et al., 1995). Using these complementary methods, transgene expression can be 
inhibited or activated in a ligand-dependent manner.   
 
In summary, inducible gene expression strategies have provided an extra level of 
conditionality in engineering the spatial - temporal dynamics of genes expression.  
 
1.2.3 Application: Regulation of cell proliferation and pluripotency 
The developmental process from totipotent cells to specific tissues is controlled 
by dynamic mechanisms. Here we review the applications of genetic engineering 
strategies for cell reprogramming towards altering the patterns of gene 







There has been considerable interest in developing strategies for optimizing 
culture conditions for cell survival and proliferation. Primary cells are of great 
interest for research and for drug discovery and regenerative therapy. However, 
the cell sources, and cell proliferation capacity are limited.  One way to overcome 
this problem is cellular immortalization, which can be seen as a bypass of cellular 
senescence. The molecular mechanisms of cellular immortalization have been 
defined (Lundberg et al., 2000; Shay et al., 1991).  
 
Two immortalization agents have been widely used: the Simian virus 40 large T-
antigen (TAg) and the catalytic subunit of telomerase (human hTERT or mouse 
mTERT). TAg is a typical tool used for cellular immortalization (Forest et al., 
1983). As a DNA tumor virus in the papovavirus family, TAg is expressed as a 
human cell-specific oncogene, thus serving to inactivate a p53 gene and Rb 
protein (Lane 1984). TAg can avoid senescence in the first stage (M1 phase) and 
facilitate immortalization, but does not maintain the telomere length, and it cannot 
be guaranteed that SV40T alone can immortalize cells completely. On the other 
hand, hTERT gene can activate telomerase within cells and maintain the 
telomere length. Therefore, by transducing a hTERT gene in combination of TAg, 
cells can overcome the M1 phase, and maintain immortalization (Bodnar et al., 
1998; Okitsu et al., 2004; Zhu et al., 1999). 
 
In addition, Cre/loxP site-specific recombination was applied to enable the 





lines that can remove the introduced immortalizing gene later by coding the 
genes between a pair of loxP sequences.  Therefore, once cells are immortalized 
by introduction of loxP-flanked immortalizing genes, they grow unlimited in tissue 
culture. After the immortalized cells proliferate to sufficient numbers, by “cutting 
out” the immortalizing gene at that stage a large amount of reverted form of cells 
with original preimmortalized status can be obtained. So far, reversible 
immortalization had been successfully applied to primary fibroblasts (Westerman 
and Leboulch 1996), human muscle satellite cells (Cudré-Mauroux et al., 2003), 
human insulin secreting beta cells (Narushima et al., 2005), and other types of 
cells (Kobayashi et al., 2001; Noguchi et al., 2002; Kowolik et al., 2004; 
Hashimoto et al., 2006). 
 
The development of pluripotent iPS cells represented a great application of 
genetic engineering in exploring new cell sources for tissue engineering and 
potentially regeneration therapy. In 2006, the Yamanaka group derived induced 
pluripotent stem cells (iPS) by the introduction of four transcription factors 
(Oct3/4, Sox2, Klf4, and c-Myc) into adult cells (Takahashi and Yamanaka, 2006; 
Takahashi et al., 2007), which may offer a source of autologous functional cells. 
One significant concern regarding the therapeutic value of iPS cells is the 
presence of proviral integrations harboring known oncogenes, particularly c-Myc, 
as well as Oct4 and Klf4. The effects of the randomly integrated retroviral vectors 
used for reprogramming represents a more fundamental defect in the 





In certain ways, reversible immortalization shares similarities with studies of 
reprogrammed (iPS) cells (Takahashi and Yamanaka, 2006; Takahashi et al., 
2007). Both strategies use lentivirus-based gene transduction to induce adult 
primary cells into dedifferentiated proliferating status, and apply growth factors to 
re-differentiate the expanded cells into specific lineages. Notably, when 
reversible immortalization is used, the expanded cells are depleted of the 
inserted genes via loxP–Cre recombination. As a result of complete gene splicing, 
cell proliferation was completely arrested, enabling the elimination of potential 
tumorigenic problems in transplantation practice.  
 
The iPS research also suggested various strategies of gene transfer for deriving 
fully functional, mature cell phenotypes. The TAg gene interacts with cell cycling-
related factors, such as p53 (Schultz et al., 2000), which induces cell proliferation, 
but is also involved in the control of DNA repair and recombination. In iPS studies, 
differentiated cell phenotypes are derived through a series of steps starting with 
early cell differentiation. In studies of reversible immortalization, the process is 
being shortened by picking the most promising clones that express specific key 
phenotypes and by regaining the lost cell phenotypes by proper stimulation after 
gene splicing. This “shortcut” strategy worked well with many cell types, such as 
human insulin-secreting beta cells (Narushima et al., 2005). If, however, the full 
phenotypic characteristics of certain cells, for example, cardiomyocytes are not 






Recently, two groups used reversible gene expression system, piggyBac, to 
develop a new generation of iPS cells. The strategy which combined the merits 
of reversible immortalization and traditional iPS studies, delivering four 
reprogramming factors within a single expression cassette in piggyBac, 
transforming the cells into iPS cells and then being able to remove the inserted 
gene cassette (Yusa et al., 2009, Woltjen et al., 2009) . After introducing this 
construct together with transposase into mouse embryonic fibroblasts, Yusa et al. 
recovered iPS colonies at frequencies of 0.1–1%, similar to those obtained with 
integrating viral vectors. Both groups confirmed absence of transgenic 
sequences in the genome by sequencing the previously identified integration 
sites and assessed pluripotency of integration-free iPS by analyzing teratoma 
and chimera formation.  
 
1.2.4  Conclusion 
In summary, major progress has been made in developing varied controlled gene 
expression systems, which offer variety of choices in managing gene expression 
in a dynamic fashion. An idea reversible gene expression system should be able 
to remove the inserted gene without a trace. While an idea inducible regulation 
system should have several key features. Basal expression should be very low, 
and be inducible to high level over a wide enough dose range to provide useful 
dose-responsive control, for example the system should resemble a rheostat 
rather than an on/off switch. Induction should be a positive effect (adding rather 





pleiotropic effects in mammalian cells. The regulatory protein(s) should also have 
no effects on endogenous gene expression, and ideally should be human in 
origin to minimize potential immunogenicity.  
 
These examples of reversible and inducible gene expression demonstrate that 
temporal control of embryonic transcription could be achieved through small-
molecule ligands and synthetic receptors. In principle, engineering methods 
could achieve more sophisticated spatial and temporal control of gene 
expression, a result not achieved thus far. 
 
1.3 The engineering strategies in patterning cell function 
Spatial and temporal regulation of gene expression drives embryonic 
development, whereas gradients in cellular–extracellular architecture exist 
throughout the human body, to satisfy spatially diverse functional needs. In order 
to engineer complex tissues, patterning strategies have been developed and 
incorporated into tissue engineering. Here we review patterning strategies, which 
includes patterning biological environment and biological factors in engineering 
heterogeneous tissues and tissue interfaces.  
 
1.3.1 Patterning the biological environments (biomaterials) 
Tissues consist of cells and extracellular matrix (ECM), and differ with each other 
in type, content, and organization of the constituent cells and ECM components. 





material based gradients, and the possible applications of these patterned 
gradients from a tissue engineering perspective.  
 
1.3.1.1 Patterning pore size and porosity 
Among several scaffold design parameters, pore size and porosity bear prime 
importance. Pore size is known to affect cellular affinity and viability by 
influencing cellular movement, binding and spreading, intracellular signaling, and 
transport of nutrients and metabolites (Oh et al., 2007) Porosity governs the 
maximum possible accommodation of cell mass in the scaffold and potential 
vascularization in vivo (Yang et al., 2001). An interconnected pore network is 
desired to minimize dead volume, and tortuosity of the network affects mass 
transport (Malda et al., 2004). Pore shapes may also critically affect the cellular 
organization in the scaffolds (Zmora et al., 2004).  
 
Because of the importance of scaffold architecture in tissue engineering, new 
techniques have been developed to produce anisotropic “biomimetic” scaffolds to 
mimic the organization of the cells or microenvironment of specific tissue with 
highly zonal architecture, and interfacial tissues. These new techniques include 
centrifugation–heat-sintering method (Oh et al., 2007), combination of melt 
pressing and porogen leaching (Schwarz et al., 1998), centrifugation–freeze 
drying method (Harley et al., 2006) and phase separation–freeze drying method 
(Vlierberghe et al., 2007; Dubruel et al., 2007). Using a three-dimensional (3D) 





gradients in porosity with near-uniform pore sizes were created (Sherwood et al., 
2002). A novel 3D fiber deposition technique was utilized in creating scaffolds 
that contained a gradient in pore size with a uniform porosity (Woodfield et al., 
2005). Based on these techniques, a prototype of graded bone implant with 
spatially varying pore size and porosity was created (Schwarz et al., 1998) and 
an anisotropic gradient-based pore architecture has been developed to engineer 
native zonal organization of the cartilage (Woodfield  et al., 2005)..  
 
1.3.1.2 Patterning substrate stiffness  
Substrate stiffness affects cellular adhesion, spreading, motility, survival, and 
differentiation (Discher et al., 2005; Li et al., 2005). Research with fibroblasts, 
epithelial cells and smooth muscle cells has demonstrated the importance of 
substrate stiffness as a physical signal for cells. Generally cell contact with the 
substrate diminishes on increasingly softer substrates (Pelham and Wang, 1997; 
Engler et al., 2004) and cells migrate from softer regions to stiffer regions when 
exposed to a gradient in substrate stiffness (Kidoaki and Matsuda, 2008; Lo et al., 
2000), a phenomenon termed “durotaxis” or “mechanotaxis”.   
 
An effective stiffness range, however, varies between cell types and leads to cell-
specific responses. For example, fibroblasts placed on various soft 
polyacrylamide substrates (shear modulus: <1.6kPa (Yeung et al., 2005); 
Young's modulus [AFM]: 14 kPa (Lo et al., 2000) ∼2.7kPa (Guo et al., 2006); 





their cytoskeletons with destabilized focal adhesions, and loss in actin filament or 
“stress fiber” expression, resulting in a rounded cellular morphology,  compared 
to corresponding stiffer substrates (shear modulus: >3.6 kPa (Yeung et al., 2005); 
Young's modulus [AFM]: 30 kPa (Lo et al., 2000) ∼7.7 kPa (Guo et al., 2006); 
Young's modulus [bulk]: 34 kPa, 12.4 kPa(Guo et al., 2006)), where these cells 
adapt a flat morphology. Neurons preferentially branch on soft substrates (50Pa) 
compared to stiff surfaces (550Pa), while the range of stiffness that is relevant to 
neurons may not affect fibroblasts (Flanagan et al., 2002). 
 
To fabricate substrates with continuous stiffness gradients at macro- and 
microscales, controlled photopolymerization processes have been utilized in the 
past, where gradients were generated by controlled photoexposure, using a 
gradient photomask (Jacot et al., 2006) or by varying photoexposure time (Lin-
Gibson et al., 2006), or by precisely altering the crosslinker concentration using a 
microfluidic device (Engler et al., 2004). In many of these early investigations, 
polyacrylamide gels served as tools to create step and continuous compliance 
substrates. Various other materials that have similarly been used to create 
substrates with continuous stiffness gradients include a two-component 
dimethacrylate blend (Lin-Gibson et al., 2006), styrenated gelatin (Kidoaki and 
Matsuda, 2008) and PEG-diacrylate (Burdick et al., 2004).  
 
In summary, the utility of stiffness gradients has so far been realized in studying 





of materials. Probing other possible cell–biomaterial combinations using 
continuous stiffness gradient surfaces may provide useful information to the 
tissue engineering community. Stiffness gradient constructs may also be useful 
in interfacial tissue regeneration; however, it will require a transition from 2D 
surfaces to 3D environments. The challenge lies in gathering further knowledge 
and combining it toward designing “active” optimal bioengineered constructs. 
 
1.3.1.3  Application: patterning ligament to bone interface 
Here in this section, we reviewed the application of above material based 
patterning strategies in generating functional tissue interface. Tissue-to-tissue 
interfaces such as those that connect soft tissue to bone are ubiquitous in the 
body, and they are essential for facilitating synchronized joint motion and 
musculoskeletal function. These critical junctions between distinct tissue types 
are, however, prone to injury and unfortunately not re-established following 
standard surgical repair methods. Failure to regenerate the intricate tissue-to-
tissue interface has been reported to compromise graft stability and long-term 
clinical outcome (Friedman et al., 1985; Lu and Jiang, 2006), consequently, 
engineering soft tissue to bone interface remain a significant clinical challenge. 
 
The detailed mechanisms that drive the development of the tendon-to-bone and 
ligament-to-bone interface are not fully understood. Published studies revealed 
that, at birth, the majority of proliferating cells at the interface were near the 





birth (Nawata et al., 2002), however this native interface is not spontaneously 
regenerated between soft tissue and bone, neither can be regenerated by 
surgery that surgically juxtaposed soft tissue and bone (Rodeo et al., 1993).  In 
order to address this problem, bio-mimetic stratified scaffold has been developed, 
coupled with spatial control over the distribution of interface relevant cell 
populations, to engineer the formation of cell type and phase specific matrix 
heterogeneity in vitro and in vivo. In a recent study, Spalazzi et al. developed a 
stratified scaffold composed of poly-α-hydroxyester nanofibers and sintered 
microspheres (Spalazzi et al., 2008). The scaffold induced compression of 
tendon grafts, which resulted in significant matrix remodeling and the expression 
of fibrocartilage interface-related markers such as type II collagen, aggrecan, and 
transforming growth factor-β3 (TGF-β3) (Figure 1.5). These results suggest that 
the stratified scaffold can be used to induce the formation of an anatomic 







Figure 1.5  Nanofiber-based scaffold for tendon-to-bone integration (A) SEM 
micrograph depicting aligned fiber organization. (B) Fluorescence microscopy of human 
rotator cuff fibroblasts cultured on aligned nanofibers, cellular attachment and alignment 
is directed by the underlying substrate morphology. Histological analysis of a bi-phasic 
scaffold after 3 weeks of subcutaneous implantation, exhibiting (C) collagen matrix 
deposition and in-growth (picrosirius red) and (D) region-dependent distribution of 
mineral (von Kossa). (Moffat et al., 2009) 
 
In summary, current strategies in material based patterning, not only validate the 
feasibility of engineering heterogeneous tissue or tissue interfaces, but also 
highlight the potential clinical application in regeneration therapy.  
 
1.3.2 Patterning biological factors 
Concentration gradients of bioactive signaling molecules, such as morphogens 





crucial role in developmental, disease, healing and regeneration process. 
Several of these bioactive factors are well characterized for different tissue 
engineering applications, are known to induce concentration-dependent cell 
type–specific responses, and usually work in a synchronized manner with other 
similar factors during the development or repair of a natural tissue, and the 
spatial and temporal availability of these molecules is integral to their ability to 
regulate these processes and control the pattern of tissue formation (Chen and 
Mooney, 2003). While these factors are traditionally delivered homogeneously for 
in vitro or in vivo tissue engineering, both temporal and spatial control over the 
delivery of such factors is an understood requirement for biomimetic repair and 
regeneration. Thereby, spatial patterning of chemical signals is a field of growing 
interest for the tissue engineering community; many bio-mimetic strategies have 
been developed to engineer spatial and temporal aspects of exogenous delivery 
of such signals in tissue engineering (Vunjak-Novakovic and Kaplan, 2006; 
Ingber et al., 2006). The following sections of this review, we briefly discuss the 
two general categories of strategies adopted in patterning biological factors: 
patterned immobilization and patterned fluidic delivery.  
 
1.3.2.1 Patterning immobilized biological factors 
The general techniques to immobilize biological factors onto the biomaterial 
surface include adsorption of the molecule on the desired surface, covalent 
linking of the peptides/proteins via peptide bond formation through carboxylic 





modified surface (for example, using carbodiimide chemistry), or by derivatizing 
with photoreactive moieties (such as azidophenyl, benzophenone, acryloyl, or 
aryl azide groups), all more or less governed by the chemistry of the 
substrate/scaffold. General methods that have been utilized to create 
immobilized chemical signal gradients in two dimensions and three dimensions 
include single- or dual-source/chamber approaches (Dodla and Bellamkonda, 
2006 & 2008; Vepari and Kaplan, 2006), pump- or gravity-driven flow of factor 
solution (Burdick et al., 2004; Dertinger et al., 2002; Moore et al., 2006; DeLong 
et al., 2005), capillary-driven flow of factor solution (Caelen et al., 2000), 
automated printing (Ilkhanizadeh et al., 2007) and adsorption or covalent linking 
of proteins utilizing polymer-grafted/micropatterned substrates (Li et al., 2005; 
Harris et al., 2006; Mei et al., 2006). Microfluidics, photopolymerization, ATRP, 
and/or protein conjugation chemistry are also adopted in engineering immobilized 
protein gradients. 
 
In a recent study, Hermanson’s group patterned extrinsic factors onto a hydrogel 
matrix to direct the state and fate of neural stem cells (NSCs) (Ilkhanizadeh et al., 
2007). In this study, they used an inkjet printer to print biologically active 
macromolecules on poly-acrylamide-based hydrogels, which were subsequently 
seeded with primary fetal NSCs. The advantage of using a hydrogel as a printing 
substrate is that, due to its high water content, it allows proteins to be hydrated 
throughout the printing procedure, protecting them against denaturation. Further, 





serve as bioimimetic extrinsic factor reservoirs as well as supporting scaffolds 
(Lutolf and Hubbell, 2005). NSCs cultured on areas printed with fibroblast growth 
factor-2 (FGF2) remained undifferentiated, consistent with the effects of FGF2 
when administered in solution. NSCs cultured in parallel on the same hydrogels 
but in areas printed with ciliary neurotrophic factor (CNTF) or fetal bovine serum 
(FBS) displayed a rapid induction of markers for astrocytic (glial fibrillary acidic 
protein, GFAP) or smooth muscle (smooth muscle actin, SMA) differentiation, 
respectively (Figure 1.6). These results are consistent with known actions of 
CNTF and FBS on NSCs. NSCs cultured on a printed gradient of increasing 
levels of CNTF showed a linear increase in numbers of cells expressing GFAP, 
demonstrating functional gradients of biologically active macromolecules can be 






Figure 1.6  Patterned neural stem cells (NSCs) with a ciliary neurotrophic factor 
(CNTF) gradient. (A) The gradient of GFAP-positive cells reflects the underlying 
gradient of printed CNTF. Individual images of areas with high (B), medium (C) or low (D) 
percentages of GFAP-positive cells (GFAP-red, nestin-green, DAPI-blue). (E) 
Quantification of the percentages of GFAP-positive cells present on six consecutive 
images acquired along the direction of the CNTF gradient, starting at the highest levels. 
This quantification was repeated on six separate slides. The percentage of cells 
expressing the GFAP ranged between 16% and 4%. (Ilkhanizadeh et al., 2007) 
 
1.3.2.2 Patterning soluble biological factors 
In the past 10 years, engineering tools have been increasingly used to develop 
experimental platforms that can generate gradients of soluble biological factors to 
allow quantitative characterization of cellular response to gradients. To control 
the cell–soluble factor interaction, conventional gradient-generators have been 





Zigmond chamber (Zigmond, 1977), and micropipette-based assay (Zheng et al., 
1994; Segall, 1993). Although the conventional gradient-generators have been 
used for studying chemotaxis and axon guidance, there are still many limitations, 
including the inability to maintain stable tempo-spatial gradients and the lack of 
the cell monitoring in a real-time manner.  
 
To overcome limitations imposed by conventional gradient-generators, PDMS 
microfluidic-based gradient devices have been recently developed (Li Jeon et al., 
2002; Abhyankar et al., 2006; Mao et al., 2003; Tourovskaia et al., 2008). 
Microfluidic devices fabricated by photo and soft lithography techniques enable 
the manipulation of fluid flow, the generation of stable concentration gradient 
profiles, and real-time monitoring of the cells (Keenan and Folch, 2008; 
Whitesides, 2006). Given these unique characteristics, microfluidic devices have 
been widely used for cell biology applications (Whitesides et al., 2001). In this 
section, we review the recent development of gradient-generating microfluidic 
platforms (i.e. flow-based and diffusion-based gradient device). 
 
Microfluidic platforms enable control of concentration gradients using laminar 
flow and diffusion transport (Figure 1.7). These devices consist of the 
serpentine-based microchannel and a cell culture area. In general, two or three 
solutions are mixed and spitted in a microchannel, resulting in generating stable 
concentration gradients in perpendicular to the flow direction. As compared to 





chemicals, various gradient profiles (i.e. single, overlapping, and dynamic switch 
gradient profile) can be rapidly generated in a single microfluidic device.  
 
Various profiles and steepness of concentration gradients can be generated in a 
single microfluidic device and the cocktail mixtures of soluble factors can be 
precisely delivered into each microchannel, resulting in performing high-
throughput experiments. In particular, we can investigate the effect of autocrine 
and paracrine signaling on cell growth and differentiation in a flow-based 
microfluidic gradient device. Furthermore, the microfabrication process to create 
flow-based microfluidic devices is relatively straightforward. The flow-based 
microfluidic devices also have some limitations, such as the inability to maintain 
secreted molecules (i.e. autocrine, paracrine signaling), the lack of minimizing 
the shear stress, the inability to generate gradient profiles in a 3-D scaffold, and 
the lack of creating chaotic mixing (Walker et al., 2005; Gunawan et al., 2006).   
 
Recently, a flow-based rapid generation of long-range concentration gradients in 
a portable microfluidic device has been reported (Du et al., 2009). Portable 
microfluidic-based gradient devices can be generated by surface tension 
(Meyvantsson et al., 2008). The difference in the surface tension between larger 
and smaller reservoirs as well as the evaporation has been employed to deliver 
the solution into the microchannel without external syringe pumps. Briefly, the 
forward and backward flow derived from a passive pump and evaporation in a 





gradients in a simple and rapid manner. Furthermore, a multi-purpose 
microfluidic system has been developed to create the combinatorial gradient 
profiles controlled by a binary multiplexer (Cooksey et al., 2009). Various flow-
based gradient patterns were generated by selecting combinations of 16 inlet 
multiplexer controlled by a programmable Labview system. In addition, multi-
component protein gradients have been generated by using the depletion effects 
in a flow-based microfluidic device (Fosser and Nuzzo, 2003).  
 
Another approach for creating concentration gradients in a microfluidic device is 
to use pure diffusion through the membrane or hydrogel for generating diffusion-
based gradients (Figure 1.7). As compared with the gradient-generating 
microfluidic device, diffusion-based microfluidic devices have several advantages, 
such as shear stress is negligible, the presence of secreted molecule is 
maintained, and gradients can be generated in a 3-D scaffold. Still, the diffusion-
based microfluidic devices cannot generate rapid and dynamic gradient profiles.  
 
Previous diffusion-based systems have generated simple gradients on a 2D 
surface. To create complex gradients in a 3-D environment, the diffusion-based 
gradient has been recently generated in a multi-layer microfluidic device 
containing hydrogels (Wu et al., 2006). The molecules in two reservoirs were 
diffused through the hydrogel in the middle layer and molecular gradients 
containing complex shapes (i.e. W-shaped, steplike, and parabolic shape) were 






Figure 1.7  The schematic designs of flow-based and diffusion-based 
microfluidic gradient devices (A) Flow-based microfluidic platforms enable the control 
of concentration gradients using laminar flow and diffusive mixing. (B) Diffusion–based 
microfluidic platforms generate concentration gradients using pure diffusion through the 
membrane or hydrogel. 
 
1.3.2.3  Application: Patterned stem cell differentiation 
Stem cell is a promising cell type for regenerative medicine and cell-based 
therapy, because it can differentiate into specific cell lineages (Vazin and 
Schaffer, 2010; Bhattacharya et al., 2009; Azarin and Palecek, 2010). Embryonic 
stem cells are derived from the blastocyst (i.e. inner cell mass), adult stem cells 
are obtained from the tissue-specific environment (i.e. bone marrow, muscle) 
(Lutolf et al., 2009). Although the potential of stem cells for treating degenerative 
diseases and human disorders, major challenges to prevent widespread use for 
clinical cell-based therapeutic applications are remained, such as the inability to 
control the growth and differentiation of stem cells in a homogeneous or 
patterned manner (Vazin and Schaffer, 2010). Conventional culture methods 
cannot control the stem cell behavior in a well-defined microenvironment. To 





developed to mimic the embryonic development as well as to understand the 
regulatory mechanism to direct embryonic and adult stem cell fate. 
 
For instance, the growth and differentiation of human neural stem cells have 
been investigated in a flow-based microfluidic device (Chung et al., 2005). Neural 
stem cells can self-renew and differentiate into three cell types, such as neuron, 
astrocyte, and oligodendrocyte. The concentration gradients of growth factor 
mixtures containing EGF, fibroblast growth factor 2 (FGF2), and platelet-derived 
growth factor were stably generated in a microfluidic device as conventional 
assays have not previously been possible. The quantitative analysis showed that 
the growth of human neural stem cells was directly proportional to growth factor 
concentrations, whereas their differentiation into astrocyte was inversely 
proportional to growth factor concentrations. Another similar study investigated 
the proliferation and differentiation of neural progenitor cells derived from human 
embryonic stem cells in an osmotic pump-based microfluidic device (Park et al., 
2009). This device mimicked to generate sonic hedgehog (Shh), FGF8, and bone 
morphogenetic protein 4 (BMP4) gradients that could be created during early 
brain development. The quantitative analysis of overlapping exogenous cytokine 
gradients (Shh/FGF8 or Shh/BMP4) showed that TuJ1-positive neurons were 
more highly expressed in Shh/FGF8 gradients as compared with Shh/BMP4 







Figure 1.8  Differentiation of human embryonic stem cell (ESC) derived neural 
progenitor cells in the microfluidic gradient chip The purity of the input cell 
population was confirmed by immunostaining (A) and flow cytometry (B) using antibody 
against Nestin. Scale bars = 100 µm (A, left) and 50 µm (A, right). A flow cytometric plot 
(B) shows the no-stain control profile (black solid line), the isotype control IgG-staining 
profile (black dotted line), and the Nestin staining profile (green solid line). After seeding 
Nestin-positive neural progenitor cells into the gradient chip, two pairs of cytokines were 
added to the culture medium: Shh and FGF8; Shh and BMP4. (C) Two different cytokine 
flows (Shh vs. FGF8 or BMP4) in the main channel in which three observation window 
columns (I, II, III) were located. (D–E) Gradient profile estimated by the computational 
simulation. (F) Visualization of the concentration gradient of fluorescent-labeled proteins 
(cholera toxin subunit B conjugated with Alexa Fluor 488 and 594). (G) Normalized color 
intensity (green fluorescence) shows that the gradient profile covers about one third of 
the main channel, implying the cytokine gradient profiles will follow the green dotted line. 
(Park et al., 2009) 
 
Another example is a diffusion-based gradient device used to culture human 
embryonic stem cells (Abhyankar and Beebe, 2007). The device developed by 





layer), microwell reservoir embedding the porous membrane with 0.2 µm pore 
diameter (middle layer), and assay microchannel (bottom layer) that could 
generate molecular gradients. A small droplet with cell suspension on an 
aperture template enabled the generation of the spatial-temporal patterning in an 
assay microchannel through the microwell reservoir. Thus, human embryonic 
stem cells were patterned on a mouse embryonic fibroblast feeder layer. 
Furthermore, normal murine mammary gland (NMuMG) epithelial cells exposed 
to the gradient of the exogenous factor were patterned on an essay microchannel 
(Figure 1.9). Therefore, these microfluidic gradient platforms could be useful 
tools for controlling embryonic development and directing stem cell fate. 
 
 
Figure 1.9  Spatial patterning of normal murine mammary gland (NMuMG) cells 
NMuMG cells are patterned in one corridor, and a gradient of the fluorophore Alexa 488 
is created in the assay channel. A porous membrane is incorporated in the microwell to 
increase the fluidic resistance of the system, and the fluorophore is added to the 
microwell. The molecules diffuse through the membrane and create a gradient in the 







1.3.3  Conclusion 
Basic concepts for formulating multiple tissue systems (Mikos et al., 2006) rely on 
one or more forms of chemical or physical stimuli, which affect cell-specific 
movement, substrate affinity, or tissue formation (Singh et al., 2008).  
Techniques to create bioactive factor gradients vary in terms of scale, accuracy, 
flexibility, and stability of gradient profiles (Rosoff et al., 2005).  
 
In summary, hydrogel-based approaches have provided many routes to generate 
soluble or immobilized bioactive factor gradients in both two dimensions and 
three dimensions, thereby has been widely used in studying the chemotaxis and 
haptotaxis. Surface modification, photopolymerization techniques and 
microfluidic strategies have been used to create gradients of surface-bound 
factors on polymeric surfaces. However, most two-dimensional (2D) gradients 
formed utilizing these techniques have been used for high-throughput screening, 
and have not necessarily been translated to 3D interfacial tissue applications. 
Even fewer attempts have been made to generate such gradients in degradable 
3D macroporous scaffolds, a prototype that constitutes a significant percentage 
of commonly used tissue engineering scaffolds. In this regard, primary issues to 
be addressed appear to pertain to the translation of many 2D physicochemical 








1.4 Combinational Strategy 
In previous section, we reviewed the importance of spatial temporal regulation of 
gene expressions in development process, and current progress on in 
developing biological strategies in regulating gene expression and engineering 
strategies in patterning varied biological factors. By far, based on these 
strategies, we are able to regulate specific gene expression in a temporal 
manner, or pattern certain cell functions at topobiological level, cellular level and 
molecular level (mainly growth factor and signaling factors). However, few efforts 
have been made in combining the biological and engineering strategies, directly 
patterning gene expression at the transcriptional level, which may lead to varied 
and sophisticated control of downstream cellular functions,  
 
Recently an alternate approach was developed in patterning localized gene 
transfection, leading to a novel strategy to pattern specific gene expression, the 
related cell function. One study patterned localized gene transduction in 
promoting local production of angiogenic molecules factor by the cells resident in 
the tissue (Ennett and Mooney, 2002). More recently, Phillips et al. presented a 
method for localizing continuous gradients onto interfacial constructs, and not 
relying on growth factor elution to induce cell differentiation (Phillips et al., 2008).  
 
Using a time-dependent dipping procedure with a motorized dip coater, a 
gradient of retrovirus encoding runt-related transcription factor 2 (Runx2) was 





the length of the collagen scaffold. When seeded with fibroblasts, the construct 
was successful in creating a gradient of osteoblastic differentiation (osteoblasts 
and fibroblasts on one construct). In vivo, the mineral distribution appeared 
biphasic after just 2 weeks. In vitro, constructs maintained a continuous mineral 
gradient for 42 days (Figure 1.10). This behavior is reminiscent of an application 
for ligament–bone interface engineering and other cartilage–bone applications 
(Tampieri et al., 2008), where tissue generation patterns did not necessarily 
adhere to the initial scaffold design. In addition, Phillips et al.’s technique induced 
a functional gradient from a strictly biochemical surface gradient.  
 
 
Figure 1.10  Continuously graded constructs for soft tissue—bone integration (A) 
Immunohistochemical staining for eGFP (pink) counterstained with hematoxylin (blue) 
revealed a gradient of Runx2—expressing cells. (B) Mineral deposition via µCT after 
42 days of in vitro culture. (C) Mineral deposition via µCT after 2 weeks of ectopic in vivo 
implantation (Phillips et al., 2008). 
 
Despite to the initial success, this local gene transfection mediated gene 
patterning may ultimately be limited in their success due to the short-term 





approach to extend, in a controllable manner, the expression of the plasmid 
encoding the factor(s) of interest is to immobilize the plasmid in a polymer 
system that enables its sustained release. Incorporation of plasmid DNA into poly 
(lactide-co-glycolide) scaffolds can lead to a significant increase in the duration of 
expression (Shea et al., 1999) and condensation of the plasmid prior to polymer 
encapsulation can significantly increase the level and duration of expression in 
vivo (Huang et al., 2005).  However, the controlled release of DNA or viral 
vectors did not ultimately address the issue of low efficiency and limited usage, 
more sophisticated strategies based on controllable gene expression should be 
adopted in patterning gene expression in a more dynamic and precise manner.  
  
1.5  Overview of the thesis  
1.5.1  Project 1: Regulation of cell proliferation - Controllable expansion of 
primary cardiomyocytes by reversible immortalization 
One of the challenges for tissue engineering is limited cell sources, especially for 
regeneration therapy. For example, heart is an organ that fails beyond repair, 
because of the intrinsic inability of the damaged heart tissue to regenerate after 
injury. Clearly, tissue engineering could be most valuable for the reconstruction 
of malformed hearts in children and the regeneration of failing hearts in adults.  
 
A great deal of effort has been spent exploring the reparative capabilities of 
exogenous stem and progenitor cells. Utilization of adult stem cells from various 





immune rejection or transmission of disease. Although adult stem cells were first 
isolated from the bone marrow, recent literature supports their presence in a 
variety of extramedullary organs including adipose tissue, dental pulp, circulating 
blood, amniotic fluid, and joint synovium(Gimble et al., 2007; Anker et al., 2003; 
Pei et al., 2008; Miura et al., 2003; Zhang et al., 2004). Limitations of the adult 
stem cells investigated include the limited capacity of mesenchymal stem cells 
(MSCs) to induce myogenesis, and the inability of skeletal myocytes for proper 
electrical coupling with cardiac myocytes. The ongoing efforts to derive 
phenotypically stable cardiac and vascular cell populations from human ESCs 
(hESCs), in numbers sufficient for tissue engineering hold promise that the 
advantages of these cells will be fully utilized (Yang et al., 2008). But, the use of 
these cells carries the risk of uncontrolled differentiation and teratoma formation. 
 
The Cre/loxP system is a measure widely used as an effective tool of gene 
targeting to evaluate function and differentiation in developmental processes of 
specific individual genes. Cre recombinase derived from Escherichia coli P1 
phage can independently perform a series of responses, including 1) recognizing 
loxP sequence consisting of 34 base pairs, and 2) binding to its recombination 
site and cutting off the intervened DNA that is coded between loxP sequences 
(Sternberg et al., 1981). Previously Cre/loxP site-specific recombination was 
applied to reversibly induce the proliferation of human cells, by transferring 
immortalization genes between a pair of loxP sequences. Once cells are 





to sufficient numbers, the immortalizing gene can be cut out by transferring Cre 
recombinase. By this method, a large amount of reverted form of cells with 
original pre-immortalized status can be obtained.  
 
We explored a new strategy for expanding the non-proliferating primary 
cardiomyocytes, by immortalization that requires the transfection of combination 
of immortalization genes (Hahn et al., 1999), followed by subsequently removal 
of these genes by Cre-loxP site recombination, thereby reversal into the 
terminally differentiated phenotype after the cells are expanded in culture. By 
using this strategy, we could expand primary cardiomyocytes by gene transfer, 
which has potential for providing large amounts of the patient’s own 
cardiomyocytes for cell therapy. 
 
We immortalized the primary rat neonatal cardiomyocytes by two different 
combinations of genes: TAg and Bmi-1/hTERT. After cells expansion, we used 
Cre mediated gene reversion, reverting immortalized cells back to cardiac 
phenotype. We demonstrated reversible transfer of cell immortalization gene can 
be used to expand primary cardiac cells to numbers that are sufficient for basic 







Y. Zhang, E. Nuglozeh, E. Toure, AM. Schmidt. G. Vunjak-Novakovic. 
Controllable Expansion of Primary Cardiomyocytes by Reversible Immortalization. 
Hum Gene Ther. (12):1687-1696 2009. 
 
1.5.2 Project 2: Patterning cells differentiation - Patterning osteogenesis by 
inducible gene expression in microfluidic systems 
During native tissue development and remodeling, the differentiating cells form 
boundaries and interfaces, in response to spatial gradients of gene expression 
and cytokines distribution, whereas the formation of transitional zones in vitro 
remains a significant challenge.  
 
We explored an alternate strategy to pattern gene expression within a cell 
population, by patterning the gene expression mdulators with a multiple - 
laminar fluidic system. The patterned delivery of gene expression modulators 
in mulitple -laminar flow system, leads to patterned gene expression, and 
subsequently patterned gene mediated cell differentiation.  
 
Using a bone–soft tissue interface as a model, we proposed a strategy to 
spatially regulate expression and secretion of the bone morphogenetic protein 
(BMP-2), by using flow patterning of inducible BMP-2 gene expression. As BMP-
2 plays an important role in osteogenesis and bone metabolism as a powerful 
inducer of osteoblast differentiation in vitro and bone formation in vivo (Hay et al., 





expression and multi-laminar fluidic system, we developed a novel approach to 
spatially regulate expression of BMP-2 within tissue-engineered constructs, and 
thereby modulated osteogenic differentiation, in engineering and studying tissue 
interface. In summary, we developed a strategy to engineer osteo-mesenchymal 
tissue interface by patterning inducible BMP-2 expression within a laminar fluidic 
system, the strategy presented a innovative method to pattern particular gene 
expression in an inducible manner.    
 
Publication: 
Y. Zhang, Z. Gazit, G. Pelled, D. Gazit, G. Vunjak-Novakovic. Patterning 
osteogenesis by inducible gene expression in microfluidic culture systems. 
Integrative Biology 3(1):39-47 2011. 
 
1.5.3 Project 3: Patterning pluripotency - Patterning embryonic cell 
differentiation by patterned inducible Nanog expression in multi-laminar fluidic 
system 
Embryonic stem cells (hESCs), derived from the blastocyst inner cell mass, 
provide a potentially unlimited supply of cells that may be directed to differentiate 
toward specific lineages and a model to study the early embryo development. 
The mechanisms by which inductive signals control the identity, proliferation and 
timing of differentiation of progenitor cells in establishing spatial pattern in 





challenges as well opportunities to develop innovative strategies in study the 
spatial control of embryonic differentiation.  
 
Our previous study demonstrated an alternative strategy to pattern gene 
expression within a cell population, by patterning the gene expression 
modulators with a multiple - laminar fluidic system. We proposed this strategy 
could be a good platform in studying and engineering the spatial control of 
embryonic differentiation.    
 
We chose an inducible Nanog expressing cells line, under control of a Nanog 
gene expression vector, composed of a shRNA fragment, suppressing cells’ 
endogenous Nanog, coupled with a Tet-on inducible expression system of 
exogenous Nanog. This unique expression vector offers precise control of Nanog 
expression in cells. As Nanog safeguards the pluripotency by reversing/ resisting 
nascent epigenetic modification, the absence of Nanog provides window of 
opportunity when intrinsic / exogenous signals consolidate into differentiation 
commitment.  Therefore by patterning the delivery of Dox to the cultured cells in 
laminar flow system, we effectively pattern the expression of Nanog expression 
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embryonic differentiation by inducible Nanog gene expression in laminar fluidic 
culture system. [In Preparation] 
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Chapter 2  Regulation of cell proliferation - Controllable expansion of 
primary cardiomyocytes by reversible gene expression  
 
2.1 Abstract 
Cardiac tissue engineering will remain only a prospect unless large numbers of 
therapeutic cells can be provided, either from small samples of cardiac cells or 
from stem cell sources. In contrast to most adult cells, cardiomyocytes are 
terminally differentiated and cannot be expanded in culture. We explored the 
feasibility of enabling the in vitro expansion of primary neonatal rat 
cardiomyocytes by lentivector-mediated cell immortalization, and then reverting 
the phenotype of the expanded cells back to the cardiomyocyte state. Primary rat 
cardiomyocytes were transduced with simian virus 40 large T antigen (TAg), or 
with Bmi-1 followed by the human telomerase reverse transcriptase (hTERT) 
gene; the cells were expanded; and the transduced genes were removed by 
adenoviral vector expressing Cre recombinase. The TAg gene was more efficient 
in cell transduction than the Bmi-1/hTERT gene, based on the rate of cell 
proliferation. Immortalized cells exhibited the morphological features of 
dedifferentiation (increased vimentin expression, and reduced expression of 
troponin I and Nkx2.5) along with the continued expression of cardiac markers 
(α-actin, connexin-43, and calcium transients). After the immortalization was 
reversed, cells returned to their differentiated state. This strategy for controlled 
expansion of primary cardiomyocytes by gene transfer has potential for providing 





cardiomyocytes derived by this method could be a useful cellular model by which 
to study cardiogenesis. 
 
2.2 Introduction 
Myocardial infarction affects more than 500,000 patients in the United States 
each year (Kirkpatrick et al., 2007), largely because of minimal endogenous 
cardiac regeneration that cannot compensate for the massive loss of 
cardiomyocytes after myocardial infarction. Tissue engineering of a functional 
cardiac patch is being studied as a potential way to replace damaged 
myocardium. However, engineering a clinically sized cardiac patch (centimeters 
in size, millimeters thick) requires large numbers of cells, because of the high cell 
density (~108 cells/cm3) that needs to be established for functional cell coupling 
and signaling (Gerecht-Nir et al., 2006). 
 
A small fraction of adult heart cells has stem cell-like properties (Moretti et al., 
2006); however, it is difficult to isolate and expand these cells in vitro, because of 
their low frequency and limited access. Transplantation of exogenous adult and 
embryonic stem cells showed improved myocardial function by increasing 
vascularization and reducing ventricular remodeling (Orlic et al., 2001; Kehat et 
al., 2004). However, these cells may generate immunogenic or tumorigenic 
problems. Breakthroughs resulting in the derivation of induced pluripotent stem 
cells (iPS) by the introduction of four transcription factors (Oct3/4, Sox2, Klf4, and 





(Takahashi and Yamanaka, 2006; Takahashi et al., 2007), and may offer a 
source of autologous functional cardiomyocytes (Mauritz et al., 2008; Narazaki et 
al., 2008). It remains to be determined whether these cells have all the properties 
of embryonic stem cells, and how much phenotypic stabilization needs to be 
done in vitro to avoid the risk of teratoma formation. 
 
A potential alternative approach is that of expanding nonproliferating primary 
cardiomyocytes, by step-wise immortalization that requires a combination of 
immortalization genes (Hahn et al., 1999), followed by reversal into the terminally 
differentiated phenotype after the cells are expanded in culture. The process of 
reversible immortalization involves transfer and expression of specific 
immortalization genes in primary cells, and the subsequently removal of these 
genes by Cre–loxP site recombination. So far, reversible immortalization had 
been successfully applied to primary fibroblasts (Westerman and Leboulch 1996), 
human muscle satellite cells (Cudré-Mauroux et al., 2003), human insulin 
secreting beta cells (Narushima et al., 2005), and other types of cells (Kobayashi 
et al., 2001; Noguchi et al., 2002; Kowolik et al., 2004; Hashimoto et al., 2006). 
Here, we explore whether this method of gene transfer may be used to expand 
primary cardiac cells to numbers that are sufficient for basic research and 
regenerative medicine applications. We selected neonatal rat cardiomyocytes as 
model cells because they represent a widely used “standard” for cardiac tissue 
engineering studies. It has been established that neonatal rat cardiomyocytes 






Figure 2.1  Experimental design for reversible immortalization of cardiac 
myocytes Freshly isolated neonatal rat cardiomyocytes were preplated for 1 hr and 
cultured in monolayer, using DMEM supplemented with bromodeoxyuridine (BrdU, 100 
µM) for 3–4 days to eliminate fibroblast contamination. The cells were then transduced 
either with lentiviral vector expressing simian virus 40 large T antigen (TAg) under the 
control of the cytomegalovirus (CMV) promoter, or with Bmi-1 vector and then human 
telomerase reverse transcriptase (hTERT) vector. The transformed cells were subjected 
to single cell cloning to yield TAg clone 8 or Bmi-1 clone 4. The cells were then infected 
with a recombinant adenovirus expressing Cre recombinase (Ad-CMV-Cre), to remove 
the TAg, Bmi-1, and hTERT genes that were flanked by loxP sites. Biophysical 
stimulation (100 µM phenylephrine [PE], 10 µM norepinephrine [NE], vascular endothelial 
growth factor [VEGF, 10 ng/ml], and dickkopf homolog-1 [DKK1, 150 ng/ml]) was applied 
to the reverted cells. 
 
after which cellular proliferation no longer occurs (Simpson and Savion, 1982; 
Long et al., 1990). For example, the 8-day culture of cell populations harvested 
from 1-day-old neonatal rat hearts resulted in a 6-fold increase in numbers of 
vascular cells and fibroblasts, and no increase in the number of cardiomyocytes 
(Long et al., 1990). This is consistent with our experience in studies of cardiac 





reversible immortalization of primary neonatal rat cardiomyocytes that were (1) 
immortalized by two different combinations of genes (simian virus 40 large T 
antigen [TAg], or Bmi-1/human telomerase reverse transcriptase [hTERT]), (2) 
expanded in culture, and (3) reversed back to cardiac phenotype (Figure 2.1). 
 
2.3 Materails and Methods  
2.3.1 Lentiviral vector production 
loxP-containing human immunodeficiency virus (HIV)-derived lentiviral vectors 
expressing enhanced fluorescent green protein (GFP), TAg, Bmi-1, and hTERT 
from an internal human cytomegalovirus (CMV) immediate promoter (Salmon et 
al., 2000) were obtained from Addgene (plasmids 12243, 12246, 12240, and 
12245; Addgene, Cambridge, MA). The recombinant retroviruses were produced 
by established methods (Naghavi et al., 2005). In brief, the lentiviral vector 
expressing the target gene, the lentiviral packaging construct (pCMVR8.91) 
encoding the HIV-1 Gag and Pol precursors, and the vesicular stomatitis virus 
(VSV) G envelope construct (pMD.G) (kindly provided by S. Goff, Department of 
Microbiology, Columbia University, NY) were cotransfected into 293T cells in the 
presence of FuGENE 6 (Roche, Basel, Switzerland). The culture fluid was 
harvested 48–72 hr posttransfection and stored at −80°C. The titer of 
recombinant viruses was >5 × 104 transduction units/ml, as determined by flow 
cytometric analysis of 293T cells or diluted colonies, counting after selection in 






2.3.2 Isolation, culture, and transduction of primary neonatal cardiomyocytes 
Primary cultures of neonatal rat ventricular cardiomyocytes were derived 
according to previously published procedures (Radisic et al., 2008). In brief, 
cardiomyocytes were obtained from 1- to 2-day-old neonatal Sprague-Dawley 
rats by means of a protocol approved by the committee on animal care at 
Columbia University (New York, NY). The ventricles were quartered, dissociated 
overnight at 4°C in a 0.06% (w/v) solution of trypsin in Hanks' balanced salt 
solution (HBSS; GIBCO, Grand Island, NY), washed in culture medium 
(Dulbecco's modified Eagle's medium [DMEM] supplemented with 10–20% fetal 
bovine serum [FBS], 10 mM HEPES, 2 mM L-glutamine, and penicillin–
streptomycin [100 units/ml]; GIBCO), and then subjected to a series of digestions 
(8 min at 37°C; 75 rpm) in a 0.1% (w/v) solution of collagenase type II in HBSS. 
The harvested cells were then pooled and resuspended in culture medium. Cells 
were preplated for one 60-min period to enrich for cardiomyocytes. The cells 
were seeded at a density of 20 × 103 cells/cm2 in 6-well plates. 
Bromodeoxyuridine (BrdU, 100 µM; Sigma-Aldrich) was added to the growth 
medium for 3–4 days to eliminate proliferating fibroblast cells and progenitor cells 
(Lokuta et al., 1994; Miragoli et al., 2006). 
 
For transduction, cardiomyocytes were exposed to lentiviral vectors at a 
multiplicity of infection (MOI) of 0.5–2 in the presence of Polybrene (10 µg/ml; 
Sigma-Aldrich) at 37°C for 6 hr (protocol adapted from Noguchi et al., 2002; 





repeated for 3–4 days. For single cell cloning, 1000 transduced cells were plated 
on a 100-mm culture dish coated with methylcellulose-based medium (R&D 
Systems, Minneapolis, MN). Colonies were isolated and expanded for 
experimentation. 
 
2.3.3 Western blots 
Cells were lysed in cell extraction buffer (Invitrogen, Carlsbad, CA). Total protein 
from lysate (15 µg per sample) was loaded for sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and the proteins were 
transferred to nitrocellulose membranes. Membranes were blocked in 10% milk 
and incubated with primary antibodies: mouse monoclonal antibodies against 
TAg and Bmi-1 (Santa Cruz Biotechnology, Santa Cruz, CA), and against TERT 
and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) (Abcam, Cambridge, 
MA) at dilutions of 1:200–1:500, followed by secondary antibodies against mouse 
IgG conjugated with horseradish peroxidase (GE Healthcare, Buckinghamshire, 
UK). Signal was detected with enhanced chemiluminescence (ECL) reagent (GE 
Healthcare). 
 
2.3.4 Cell growth kinetics 
Primary heart cells isolated from neonatal rat were transduced with lentiviral 
vectors expressing TAg or Bmi-1/hTERT genes, and their growth kinetics were 
monitored by measuring the cell number in each of the first 6–8 passages of 





was defined as log N/log 2, where N is the number of cells harvested at 
confluence divided by the number of cells initially seeded. Alternatively, DNA was 
measured with a PicoGreen dsDNA kit (Invitrogen) according to the 
manufacturer's protocol. The cytotoxicity of adenovirus was tested in a 3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-
Aldrich). 
 
2.3.5 Reversal to differentiated cell phenotype 
Purified adenoviral vector expressing Cre recombinase under the control of the 
CMV promoter (Ad-CMV-Cre) (Vector Biolabs, Philadelphia, PA) was stored at 
−80°C at a titer of 2 × 107 transduction units/ml. TAg-transduced or Bmi-1/hTERT-
transduced cells were infected with Ad-CMV-Cre at an MOI of 100–500 for 6–
12 hr. The medium was then replaced with growth medium and the Cre-
transduced cells were continuously cultured for another 4 days and passaged, to 
measure the proliferation capability of cells after Ad-CMV-Cre transduction. For 
further phenotype characterization experiments on the transduced cells after 
reversal, the cells were transduced by Ad-CMV-Cre at the required concentration 
(TAg clone 8, MOI: 300; Bmi-1/hTERT clone 4, MOI: 400) and were maintained 
in differentiation medium: DMEM–F12 containing penicillin–streptomycin 
(100 units/ml), 2 mM L-glutamine, 5% heat-inactivated FBS, insulin (10 µg/ml), 
transferrin (5.5 µg/ml), and sodium selenite (6.7 ng/ml) (Sigma-Aldrich) and 





(NE) (Sigma-Aldrich) or with vascular endothelial growth factor (VEGF, 
10 ng/ml)/dickkopf homolog-1 (DKK1, 150 ng/ml; R&D Systems). 
 
2.3.6 Immunofluorescence studies of marker expression 
Cells were fixed in 4% paraformaldehyde for 20 min at room temperature, 
blocked with 10% horse serum (Vector Biolabs) for 40 min at room temperature, 
and then incubated for 1 hr at 37°C with primary antibodies: mouse anti-cardiac 
troponin I (diluted 1:150; Biodesign, Saco, ME), mouse anti-sarcomeric α-actin 
(diluted 1:150; Sigma-Aldrich), rabbit anti-connexin-43 (Cx-43, diluted 1:150; 
Chemicon, Temecula, CA), rabbit anti-vimentin (diluted 1:150; Chemicon), and 
rabbit anti-Nkx2.5 (diluted 1:50; Santa Cruz Biotechnology) in phosphate-
buffered saline (PBS) containing 0.5% Tween 20 and 1.5% horse serum. 
Subsequently, the cells were incubated with secondary antibodies: Texas red-
conjugated horse anti-IgG (diluted 1:200; Chemicon) and fluorescein-conjugated 
horse anti-mouse IgG (diluted 1:200; Chemicon). The nuclei were costained with 
4′,6-diamidino-2-phenylindole (DAPI, diluted 1:1000; Vector Biolabs). The images 
were captured by fluorescence microscopy (IX81; Olympus, Tokyo, Japan) and 
the MetaMorph program (Molecular Devices, Downingtown, PA). The Matlab 
program CONNEXINMEASUREMENT, developed by our laboratory (Tandon et 
al., 2009), was adapted to quantify the presence of Cx-43 protein. The number of 
instances of Cx-43 was measured in n > 40 sections per experimental group, and 






2.3.7 Calcium transients 
The excitation–contraction coupling between cells was evaluated by measuring 
calcium transients. Briefly, cells were grown in 35-mm tissue culture dishes for 2–
3 days until 70–80% confluent and loaded with 2 µM Fluo-4 (Molecular 
Probes/Invitrogen, Carlsbad, CA) in PBS for 30 min at 37°C, washed with PBS, 
and incubated in growth medium for another 30 min to allow complete 
deesterification of intracellular acetoxymethyl ester (AM). Last, the cells were 
loaded with pulsing buffer containing 255 mM sucrose, 1 mM CaCl2, 1 mM MgCl2, 
and 5 mM HEPES (conductivity, 500 µS/cm). A pair of carbon electrodes (1/8-in. 
diameter, spaced 3.2 in. apart; Ladd Research Industries, Williston, VT) was 
connected to an electrical stimulator (Grass Technologies, West Warwick, RI) via 
a platinum wire (Ladd Research Industries) and placed in the tissue culture 
chamber. For excitation, field stimulation was applied at a frequency of 0.3–1 Hz, 
current pulses of 2 to 100 msec in duration, and a signal amplitude of 1–
34.2 V/cm. Calcium transient images were acquired with a fluorescence 
microscope (IX81; Olympus), stored, and analyzed digitally with the ImageJ 
program (National Institutes of Health, Bethesda, MD). For each image, 
fluorescence intensity was integrated over the entire cell culture space and 
corrected by subtracting the background fluorescence measured for an area of 









2.4.1 Lentivector-mediated conditional immortalization of primary 
cardiomyocytes 
Cardiomyocytes isolated from neonatal rat left ventricles were treated with BrdU 
(100 µM), a mitotic inhibitor, which binds to the newly synthesized DNA during 
the S phase of the cell cycle, substituting for thymidine during DNA replication. A 
high concentration of BrdU in vitro effectively blocked the proliferation of dividing 
cells (see Supplementary Figure. 2.2), including fibroblasts and progenitor cells, 
presumably because of activation of classical apoptosis pathways in BrdU-
incorporating cells (Xia et al., 1995; Caldwell et al., 2005). After BrdU 
incorporation, the cardiac fibroblasts could not be passaged (Lokuta et al., 1994; 
Miragoli et al., 2006) or transduced by lentivirus-mediated TAg or Bmi-1/hTERT 
transfection. Likewise, we were not able to produce any clones from the BrdU-
treated fibroblasts. 
 
Approximately 10–20% of the purified cardiomyocytes exposed to lentiviral vector 
expressing GFP from the CMV promoter at an MOI of 2 were transduced (see 
Supplementary Figure 2.1C). By the same cell preparation protocol, DNAs 
encoding TAg, Bmi-1, hTERT were introduced by lentivector-mediated 
transduction into cardiomyocytes, either alone or in combinations. Insertion of the 








Figure 2.2  Western blot analysis of lentiviral vectors Expression of TAg and Bmi-
1 followed by hTERT in infected cells was determined before and after Cre expression. 
(A) Lane 1, TAg clone 8 cells (passage 11) after Cre expression; lanes 2 and 3, TAg 
clone 8 cells before Cre expression (passage 11 and passage 3, respectively). (B) Lane 
1, Bmi-1/hTERT clone 4 cells (passage 8) after Cre expression; lane 2, Bmi-1/hTERT 
clone 4 cells before Cre expression. 
 
Cells quickly responded to TAg gene by increased cell proliferation, within 1–2 
weeks of transduction. In contrast, cells transduced with Bmi-1/hTERT exhibited 
a significant delay before starting to form stabilized proliferative clones (Figure 
2.3). The delay was probably due to the low Bmi-1-induced immortalization 
frequency (Hashimoto et al., 2006) and slow cell proliferation rate in the single 
cell cloning process. Therefore, we repeatedly transduced cells with Bmi-1 vector 
(three or four times), followed by transduction of hTERT three or four times to 
increase the immortalization frequency (protocol adapted from Noguchi et al., 
2002; Kowolik et al., 2004). Without hTERT transduction, Bmi-1-transformed 
cells undergo replicative senescence within five passages. With only hTERT, 
primary cardiomyocytes cannot be transduced, as evidenced by the lack of clone 







Figure 2.3  Proliferation of immortalized cardiomyocytes The proliferation of 
cardiac myocytes transduced with TAg or with Bmi-1/hTERT in the first six to eight 
passages of culture in the laboratory. Cell growth kinetics was monitored by measuring 
accumulated population doublings. Cell culture medium was DMEM supplemented with 
10% FBS, 10 mM HEPES, 2 mM L-glutamine, and penicillin–streptomycin (100 U/ml). 
 
The average doubling time of TAg-containing cells (TAg clone 8) was 0.98 days, 
whereas the average doubling time of Bmi-1/hTERT-containing cells (Bmi-
1/hTERT clone 4) was 3.84 days (Figure 2.3). When cells were seeded at a 
higher density of 104 cells/cm2 and cultured in growth medium containing 20% 
FBS, the doubling time fell to 2.5 days for Bmi-1/hTERT-transduced cells (Bmi-
1/hTERT clone 4). TAg-transduced cells had more compact cell morphology, a 
lower tendency to align or flatten (Figure 2.4), and tended to form nodules, 
whereas Bmi-1/hTERT-transduced cells maintained contact inhibition and did not 







Figure 2.4  Cell morphology (A) TAg-transduced cells on day 7. (B) TAg clone 
8 cells. (C) Bmi-1/hTERT-transduced cells on day 13. (D) Bmi-1/hTERT clone 4 cells. 
Cells immortalized with Bmi-1 and hTERT appeared large and elongated, whereas TAg-
containing cells were smaller in size and more rounded in shape. Scale bars: 100 µm. 
 
Remarkably, some of the Bmi-1/hTERT-transduced cells maintained contractile 
activity until passage 3 or 4. When the derived cells were seeded at low density 
onto methylcellulose-coated plates, they proliferated and formed well-defined 
colonies. In total, 28 clones of TAg-transduced cells and 7 clones of Bmi-
1/hTERT-transduced cells were isolated. None of the colonies showed contractile 
activity beyond passage 3 or 4. We scanned all the clones on the basis of 
immunostaining (Cx-43, α-actin, and vimentin) and morphology, and then 








2.4.2 Reversal of cell immortalization after Cre recombinase expression 
 
Figure 2.5  Effect of multiplicity of infection (MOI) on cell proliferation Cells were 
harvested, counted, and cultured 4 days after Cre transduction. Baseline: initial seeding 
cell number. After high-dose Cre transduction (MOI, 300 for TAg clone 8; MOI, 400 for 
Bmi-1/hTERT clone 4), the transfected cells stopped growing as confirmed by lack of 
proliferation in the next passage. Data are shown as averages ± SD (n = 4). 
 
Both TAg- and Bmi-1/hTERT-transduced cells proliferated without apparent 
senescence for more than 6 months of culture. To totally reverse the 
immortalization by Cre–loxP site recombination, we tested the infection of the 
transduced cells with adenovirus expressing Cre recombinase (Ad-CMV-Cre) at 
various concentrations (MOI, 100–500). Only at a high concentration (TAg clone 
8, MOI ≥ 300; Bmi-1/hTERT clone 4, MOI: 400) of Ad-CMV-Cre transduction did 
cell proliferation completely cease for the duration of the study (Figure 2.5). The 
high MOI adenovirus transduction was probably due to the limited expression of 





coxsackievirus and adenovirus receptor (CAR) (Li et al., 1999) and heparan 
sulfate proteoglycans (HSPGs) (Fender et al., 2008). The removal of 
immortalization genes from the cellular genome was confirmed by Western blot 
(Figure 2.2). After 6 hr of incubation with adenoviral vector Ad-CMV-Cre, the 
bioactivity of control cells (nontransduced cells) was reduced by 12.30% (MOI, 
300) or 35.71% (MOI, 400) by MTT measurement. 
 
Figure 2.6  Phenotypic characterization of transduced cardiomyocytes (A–C) 
Cx-43 (FITC) and α-actin (Texas red) staining of (A) primary cardiomyocytes, (B) TAg 
clone 8 cells, and (C) Bmi-1/hTERT clone 4 cells. (D–F) Troponin (FITC) and vimentin 
(Texas red) staining of (D) primary cardiomyocytes, (E) TAg clone 8 cells and (F) Bmi-
1/hTERT clone 4 cells. (G–I) Nkx2.5 (FITC) staining of (G) primary cardiomyocytes, (H) 
TAg clone 8 cells, and (I) Bmi-1/hTERT clone 4 cells. (J–K) Isotype controls for (J) 
primary cardiomyocytes, (K) TAg clone 8 cells, and (L) Bmi-1/hTERT clone 4 cells. Scale 






2.4.3 Phenotype characterization of transduced cells before and after reversal 
Immunofluorescence analysis of transduced cells showed expression of α-actin, 
a prototypical Z-line protein in cardiomyocytes, and Cx-43, a connexin gap 
junction protein in cardiac muscles (Figure 2.6). TAg clone 8 cells exhibited 
normal patterns of Cx-43 expression in cell junctions, whereas Bmi-1/hTERT 
clone 4 cells did not exhibit these cardiac-specific patterns. Both clones had low 
expression of troponin I, a regulatory protein for cardiac muscle contraction; low 
expression of Nkx2.5, a transcription factor related to cardiac differentiation; and 
high expression of vimentin, which was consistent with the dedifferentiation of 
cells during transformation (LaFramboise et al., 2007; Nakamura et al., 2008). 
Both clones maintained Cx-43 and α-actin expression; however, only TAg clone 
8 exhibited localized Cx-43 expression in cell–cell junctions. 
 
We tested a group of biochemical simulation factors including 100 µM PE and 
10 µM NE, and growth factors including VEGF (10 ng/ml) and DKK1 (150 ng/ml), 
on postexpansion differentiation. Cx-43 quantification, using a Matlab program 
(Tandon et al., 2009), showed that the frequency of Cx-43 in primary 
cardiomyocytes (2.87 per cell) decreased after TAg-induced transformation (to 
1.52 per cell) and then increased again after Cre recombinase reversion (to 1.62 
per cell) as well as after stimulation with PE (to 1.72 per cell) and growth factors 
DKK1 and VEGF (to 2 per cell). Growth factor stimulation and NE also led to 





(Figure 2.7); however, these stimulations still could not generate well-developed 
cardiac-specific patterned Cx-43. 
 
 
Figure 2.7  Phenotypic characterization of reverted clones after Cre 
transduction (A–C) Cx-43 (FITC) and α-actin (Texas red) staining of TAg clone 8 cells 
after Cre transduction (A) TAg clone 8 cells after Cre transduction and PE stimulation (B) 
and TAg clone 8 cells after Cre transduction and GF stimulation (C). (D–F) Cx-43 (FITC) 
and α-actin (Texas red) staining of Bmi-1/hTERT clone 4 cells after Cre transduction (D) 
Bmi-1/hTERT clone 4 cells after Cre transduction and NE stimulation (E) and Bmi-
1/hTERT clone 4 cells after Cre transduction and GF stimulation (F). PE, phenylephrine 
(100 µM); NE, norepinephrine (10 µM); GF, VEGF (10 ng/ml) and DKK1 (150 ng/ml). 
Scale bars: 50 µm. 
 
2.4.4 Spontaneous and induced calcium transients in immortalized cells 
Primary cardiomyocytes exhibited spontaneous contractions associated with 
calcium transients, with the fastest transient rate observed at a frequency of 2 Hz, 
which is in the physiologic range for rats (Figure 2.8A). When contractile function 
was induced by electrical stimulation, primary cardiomyocytes showed excitable 
calcium transients in a relatively lower electrical field (20 V/cm) and short pulse 






Figure 2.8  Calcium transients in primary cardiomyocytes and transduced cells 
(A) Spontaneous and paced calcium transient in primary cells (stimulation: 20 V/cm, 1 Hz, 
2-msec duration). (B) Spontaneous and paced calcium transient in TAg clone 8 cells 
before and after Cre expression with growth factor treatment. (Before Cre expression, 
stimulation: 34.2 V/cm, 0.3 Hz, 100-msec duration; After Cre expression and growth 
factor treatment, stimulation 1: 34.2 V/cm, 0.3 Hz, 100-msec duration; stimulation 2: 
34.2 V/cm, 1 Hz, 2-msec duration). (C) Spontaneous and paced calcium transient in Bmi-
1/hTERT clone 4 cells before and after Cre expression with growth factor treatment 






TAg clone 8 cells also exhibit spontaneous calcium transients at much lower 
frequency (<0.2 Hz), and they could only be excited at lower frequency (0.3 Hz) 
with a higher electrical field (34.2 V/cm) and longer pulse duration (100 msec) 
(Figure 2.8B). Bmi-1/hTERT clone 4 cells were quiescent and did not undergo 
any apparent changes in calcium content, when given the same stimulation as 
TAg clone 8 cells (Figure 2.8C). 
 
After Cre transduction, the reverted TAg-transduced cells showed increased 
spontaneous calcium transients at a frequency of 1 Hz (VEGF and DKK1 
treatment; Figure 2.8B) or ~0.25 Hz (NE, PE, or Cre only; see Supplementary 
Figure 2.3E, G, and C). With electrical stimulation at 34.2 V/cm and a pulse 
duration of 100 msec, all reverted TAg-transduced cells could be excited except 
for the nontreatment group (Supplementary Figure 2.3C, E, G, and I). After 
VEGF and DKK1 treatment, reverted TAg-transduced cells exhibited an 
increased excitable calcium response frequency up to 1 Hz, suggesting 
enhanced cell excitability after removing the TAg gene and growth factor 
stimulation (Supplementary Figure 2.3I). In contrast, after removing the Bmi-
1/hTERT gene, these effects were not seen—the cells exhibited enhanced 
spontaneous transients (<0.2 Hz) and increased amplitude of calcium changes, 
but could not respond to electrical stimulation. After VEGF and DKK1, PE, or NE 
treatment, reverted Bmi-1/hTERT-transduced cells exhibited enhanced 





changes; however, the cells did not show paced transients in response to 
electrical stimulation (Supplementary Figure 2.3D, F, H, and J). 
 
2.5 Discussion 
Our experiments show that reversible immortalization has the potential to 
generate large numbers of patient-specific cells for cardiac tissue engineering. 
First, we proved lentiviral vectors were efficient in introducing genes into primary 
cardiomyocytes; approximately 10–20% of the purified primary cardiomyocytes 
could be infected with lentiviral vector at an MOI of 2. The high transduction 
efficiency of lentiviral vector was the result of their ability to mediate stable 
integration and long-term expression of transgenes in a wide variety of targets 
irrespective of their proliferative status (Salmon et al., 2000). However, potential 
insertional mutagenesis may occur through the random integration of inserted 
lentiviral vectors; site-specific insertion by adeno-associated virus (AAV)-
mediated transduction may be a promising option for future work. 
 
We compared the application of two frequently used immortalizing genes (Cudré-
Mauroux et al., 2003): TAg, which acts through the binding of retinoblastoma 
protein (Rb) and p53 (Ali and DeCaprio, 2001), and Bmi-1, which downregulates 
the p16 and p19Arf tumor suppressor genes encoded by the ink4a locus (Jacobs 
et al., 1999), and is often combined with human telomerase (hTERT) (Hashimoto 
et al., 2006). Lentivector-mediated transduction of TAg alone, or of Bmi-1/hTERT, 





they acquired the ability to proliferate over prolonged periods of time (up to 6 
months of continuous culture during our studies). In contrast, Bmi-1 alone was 
not able to sustain continuous cell growth. Consistently, the cell phenotypes 
associated with the transduction of these two sets of immortalization genes were 
distinctly different. The TAg gene was expressed at high levels, and induced fast 
cell proliferation without a lag phase, which led to cells arranged in colonies and 
round in shape, aggregating and growing without contact inhibition in most 
clones. In contrast, Bmi-1/hTERT transduction delayed cell proliferation, which 
occurred at a much slower rate, and Bmi-1/hTERT-transduced cells exhibited 
more extended cell morphology, and maintained the contact inhibition growth 
pattern in all clones, which was possibly due to the low levels of gene expression. 
The method established in this study enabled us to start with a small number of 
primary cells (<600,000), transform the cells, and derive stable TAg-transduced 
clones within approximately 3 weeks. The method could potentially be used to 
derive large numbers of repair cells from a small biopsy sample. 
 
Interestingly, certain phenotype characteristics of primary cardiomyocytes 
(expression of α-actin, patterned Cx-43, and spontaneous and induced calcium 
transients) were conserved through multiple generations of TAg-transduced cells. 
In particular, the excitation–contraction coupling measured as calcium transients 
showed that the sarcoplasmic reticulum of TAg clone 8 cells was still able to 
release calcium in response to electrical stimulation. The lack of response to 





restoration of excitability, because intracellular calcium in these cells may return 
to the basal level more slowly than in primary cardiomyocytes. The presence of 
cardiac-specific features in Bmi-1/hTERT-transduced cells was less evident than 
in TAg-transduced cells (the expression of α-actin was conserved, but Cx-43 
patterning and calcium responses were not). 
 
After adenovirus-mediated Cre recombinase expression, which spliced the 
inserted genes, we noticed a complete arrest of cell proliferation and increased 
expression of Cx-43 in TAg-transduced cells. To redifferentiate cardiac 
phenotypes in those reverted cells, we tested a group of biochemical stimulatory 
molecules including PE, NE, VEGF, and DKK1. PE and NE are pharmacologic 
agents, used in clinics to elicit varied effects on vascular resistance, myocardial 
contractility, and heart rate (Coons and Seidl, 2007). Cellular studies showed that 
PE or NE could further induce sarcomere formation in some transformed cardiac 
cells (Rybkin et al., 2003). In our studies, the supplementation of culture medium 
with PE or NE enhanced the expression of α-actin as well as Cx-43 in reverted 
cells. VEGF and DKK1 are growth factors used in the cardiovascular 
differentiation of embryonic stem cells, through stage-specific inhibition of Wnt 
signaling (Yang et al., 2008). VEGF and DKK1 enhanced the expression of α-
actin and Cx-43 in both TAg-transduced and Bmi-1/hTERT-transduced cells after 
reversion. Stimulation with VEGF and DKK1 also increased the calcium transient 
frequency in reverted TAg-transduced cells, suggesting improved capacity of the 





Our findings are consistent with the previous findings that Wnt signaling and 
VEGF are important modulators of Cx-43 expression in cardiomyocytes (Ai et al., 
2000; Yamada et al., 2005). Because inappropriate expression of Wnt signaling 
had been found in a variety of cell transformations (Smalley and Dale, 1999), we 
hypothesized that Wnt signaling was triggered during cell immortalization, 
causing the loss of some properties of the cardiac phenotype, such as the 
decrease in Cx-43. Therefore, modulation of Wnt signaling with growth factors 
may present a method to redifferentiate the cardiac phenotype after reversion. 
Taken together, these data suggest that the immortalization of terminally 
differentiated cardiac myocytes could have practical value. Further phenotypic 
analysis of the cells in vivo should be included for future study, in order to better 
characterize the functional value of the reversible immortalization of 
cardiomyocytes. 
 
This study shares some similarities with studies of reprogrammed (iPS) cells 
(Mauritz et al., 2008; Narazaki et al., 2008). Both strategies use lentivirus-based 
gene transduction to induce adult primary cells into dedifferentiated proliferating 
status, and apply growth factors to redifferentiate the expanded cells into specific 
lineages. Notably, when reversible immortalization is used, the expanded cells 
are depleted of the inserted genes via loxP–Cre recombination. As a result of 
complete gene splicing, cell proliferation was completely arrested, enabling the 





The iPS research suggested various strategies of gene transfer toward deriving 
fully functional, mature cell phenotypes. The TAg gene interacts with cell cycling-
related factors, such as p53 (Schultz et al., 2000), which induces cell proliferation, 
but is also involved in the control of DNA repair and recombination. In iPS studies, 
differentiated cell phenotypes are derived through a series of steps starting with 
early cell differentiation. In studies of reversible immortalization, the process is 
being shortened by picking the most “promising” clones that express specific key 
phenotypes and by regaining the lost cell phenotypes by proper stimulation after 
gene splicing. This “shortcut” strategy worked well with many cell types, such as 
human insulin-secreting beta cells (Narushima et al., 2005). If, however, the full 
phenotypic characteristics of cardiomyocytes are not restored (in particular, the 
contractile function), we may need to implement some of the strategies used to 
derive iPS cells. 
 
2.6 Conclusion 
In summary, the strategy for controlled expansion of primary cardiomyocytes by 
gene transfer has the potential to provide large amounts of a patient's own 
cardiomyocytes for cell therapy. Further studies are needed to determine 
whether the phenotypic properties of reversed cells are sufficient for cell therapy 
of the heart. In turn, because of the partial expression of the cardiac phenotype, 







2.7 Supplemental Information 
 
Supplemental figure 2.1  Purification and transduction of primary 
cardiomyocytes (A) FACS data. (B) Immunofluorescence of primary cardiomyocytes 
after preplating and BrdU treatment, showing that most cells were troponin (FITC) 
positive and vimentin (PE or Texas red) negative. (C) Primary cardiomyocytes 
transduced with lentiviral vector expressing GFP (MOI, 2). Scale bar: 50 mm. 
 
 
Supplemental figure 2.2 Proliferation of primary neonatal cardiomyocytes with 
BrdU or without BrdU treatment (100 mM). Cell growth kinetics was monitored by 
measuring total DNA quantification. Cell culture medium was DMEM supplemented with 







Supplemental figure 2.3 Calcium transient in TAg clone 8 and Bmi-1=hTERT 
clone 4 Spontaneous and paced calcium transient (stimulation: 34.2V/cm, 0.3 Hz, 100 
ms duration; stimulation 2: 34.2V/cm, 1 Hz, 2 ms duration) in TAg clone 8 before (A) and 
after Cre expression (C), with NE (E), PE (G) or GF treatment (I). Spontaneous and 
paced calcium transient (stimulation: 34.2V/cm, 0.3 Hz, 100 ms duration) in Bmi-
1/hTERT clone 4 before (B) and after Cre expression (D), with NE (F), PE (H) or growth 
factor treatment (J). PE: phenylephrine 100 mM; NE: norepinephrine 10 mM; GF: 10 
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Chapter 3  Patterning stem cells differentiation - Patterning osteogenesis 
by inducible BMP-2 expression in microfluidic systems 
 
3.1 Abstract 
The development of transitional interfacial zones between adjacent tissues 
remains a significant challenge for developing tissue engineering and 
regenerative medicine strategies. Using osteogenic differentiation as a model, we 
describe a novel approach to spatially regulate expression and secretion of the 
bone morphogenetic protein (BMP-2) in a two-dimensional field of cultured cells, 
by flow patterning the modulators of inducible BMP-2 gene expression. We first 
demonstrate control of gene expression, and of osteogenic differentiation of the 
cell line with inducible expression of BMP-2. Then we design laminar flow 
systems, with patterned delivery of Doxycycline (Dox), the expression modulator 
of BMP-2. The patterned concentration profiles were verified by computational 
simulation and dye separation experiments. Patterned differentiation experiments 
conducted in the flow systems for three weeks showed the Dox concentration 
dependent osteogenic differentiation, as evidenced by mineral deposition. In 
summary, by combining inducible gene expression with laminar flow technologies, 
this study provided an innovative way to engineer tissue interfaces. 
 
3.2 Introduction 
Highly organized structures are a defining feature of biological tissues. Among 





function. For example, in musculoskeletal systems, the interface between bone 
and soft tissue facilitates transmission of mechanical loads and minimizes stress 
concentration in junctions (Thomopoulos et al., 2003). Without adequate tissue 
interaction in such junctions, conventional soft tissue grafts fail at the bone 
insertion site (Woo et al., 2006). An important goal in cell and tissue engineering 
is therefore to recapitulate tissue interfaces, if the organization of the engineered 
tissue is to reflect that of native tissue.  
 
Numerous regeneration approaches have been investigated to reconstruct 
functional tissues interfaces. The layered structure combined with multiple-phase 
culture is commonly used to pattern different cells, and construct tissue 
interfaces (Mitsuhashi et al., 1993). One strategy to engineer osteochondral 
tissue interface is to fabricate a polymer scaffold consisting of two layers of 
materials with distinct properties—such as porosity, mechanical strength and 
material microstructure, to mimic the natural environment for bone and cartilage 
development. These scaffolds are seeded with either human mesenchymal stem 
cells or pre-differentiated chondrocytes and osteoblasts and the tissue formation 
is investigated in vitro or in vivo studies (Che et al., 2006; Shao et al., 2006; 
Chang et al., 2004; Tuli et al., 2004). However this approach is restricted by 
inherent discontinuities across different materials (Spalazzi et al., 2006). Growth 
factors and chemokines can serve as powerful long-range mediators of cellular 
organization and function (Chung et al., 2005). Thus, constructing growth factor 





interfaces. In some studies, sustained release of growth factors incorporated into 
polymer scaffolds facilitated bone and cartilage differentiation in vitro and in vivo 
(Li et al., 2006; Hosseinkhani et al., 2007; Boyan et al., 1999). However the dose 
of growth factors in these scaffold systems was not well defined, due to the lack 
of optimal techniques to deliver and maintain growth factor signals in engineered 
constructs (Langer, 1998).  
 
Recent studies have focused on alternative strategies, by directly modulating 
spatial patterns of gene expression within a cell population, thereby modulating 
the functions of cells. Ziauddin and Sabatini demonstrated that gene expression 
could be patterned in culture via a reverse transfection procedure wherein 
plasmid DNA was immobilized on a substrate onto which a monolayer of cells 
was subsequently grown (Ziauddin and Sabatini, 2001). But this approach has 
been limited by the low efficiency of plasmid transfection. To alleviate the 
limitations of plasmid-based transfection, more efficient viral vectors (which may 
present safety issues) have been used to construct tissue interface by spatial 
regulation of gene transfer (Phillips et al., 2008).  
 
In the present study we proposed a new strategy to pattern cell differentiation by 
patterning gene expression modulator within laminar fluidic system. When 
parallel laminar streams of different liquids flow inside a channel at a low 
Reynolds number (Re < 1), there is no mixing between these adjacent streams, 





for separations or patterning of the cells and factors (Takayama et al., 1999; 
Kenis et al., 1999; Rhee et al., 2005; Takayama et al., 2003). The generation of 
specific patterns by using such fluidic methods is rather straightforward, as the 
characteristics of the fluidic environment can be tightly controlled. 
 
We chose an inducible BMP-2 expressing cell line (C9) under the control of Tet-
off gene expression system. This model can provide efficient control of BMP-2 
gene expression by modulating the concentration of BMP-2 expression 
modulator doxycycline (Dox) (Figure 3.1). BMP-2 belongs to the transforming 
growth factor superfamily and plays an important role in osteogenesis and bone 
metabolism, serving as a powerful inducer of osteoblast differentiation in vitro 
and bone formation in vivo (Hay et al., 1999; Ruhe et al., 2004). Therefore, by 
patterning the delivery of Dox to the cultured cells in laminar flow system, we can 
effectively pattern the expression of BMP-2 and thereby modulate osteogenic 
differentiation (Figure 3.2A). 
  
Figure 3.1  Biological model of inducible BMP-2 expression under Tet-off gene 
expression Dox concentration dependent BMP-2 expression leads to concentration-







Figure 3.2  Experimental system (A) Strategy for patterning osteogenic cell 
differentiation. Cultured cells with inducible BMP-2 expression are exposed to laminar 
flow with two streams (one with and one without Dox), generating a pattern of Dox 
concentration. The patterned Dox concentration profile leads to patterned BMP-2 
expression, and thereby to patterned osteogenic differentiation. (B) Flow channel (main 
channel: 20 mm L × 6 mm W × 0.1 mm H). 
 
First, we characterized the inducible BMP-2 expression cell line (C9) in static 
culture, and proved that BMP-2 secretion was dependent on Dox concentration 
(0–1 ng ml−1). By modulating Dox concentration, we could modulate the BMP-2 
mediated osteogenic differentiation, as verified by calcium deposition and 
alkaline phosphatase (ALP) analysis. Then we designed a laminar-fluidic system 
microfluidic channel (Figure 3.2B). These fluidic systems can deliver different 
levels of Dox concentration to cultured monolayers of cells. In 3-week 





osteogenesis in a mesenchymal stem cell line can be achieved by patterning 
BMP-2 gene expression modulator, Dox. 
 
We also developed a larger fluidic chamber (Supplemental Figure 3.1) and 
successfully replicated the same method for patterned osteogensis over a larger 
field of cells. In addition to the scale up to larger cell numbers, this fluidic 
chamber can accommodate cultivation of cells in a scaffold sheet or a layer of 
hydrogel for generating a 3D tissue interface. 
 
3.3 Materials and Methods 
3.3.1 Cell culture and osteogenic differentiation 
The BMP-2 inducible expression cell line (C9 cell) was orginated from 
C3H10T1/2 murine MSCs cell line after transfection with the human BMP-2 gene 
under control of the inducible Tet-off system (Moutsatsos et al., 2001; Noël et al., 
2004). The C9 cells were cultured in basic medium: Dulbecco's Modified Eagle's 
Medium (DMEM) (Fisher, Pittsburg, PA) supplemented with 10% fetal bovine 
serum (Fisher), 2 mM L-glutamine, 100 U ml−1 penicillin, 100 µg ml−1 
streptomycin (Invitrogen, Carlsbad, CA), and 1 µg ml−1 Dox (Sigma-Aldrich, St 
Louis, MO) to repress BMP-2 secretion. Every 2–3 passages, C9 cells were 
subjected to selection medium: basic medium supplemented with 500 mg ml−1 
G418, 200 mg ml−1 hygromycin (Sigma-Aldrich), and 1 µg ml−1 Dox to eliminate 
the cells which lost their genotype. For osteogenic differentiation, C9 cells were 





sodium-b-glycerophosphate, 0.05 mM ascorbic acid-2-phophate (Sigma-Aldrich) 
and with or without Dox added. Medium was changed twice a week.  
 
3.3.2 BMP-2 and DNA 
Secretion of BMP-2 into culture medium was measured by BMP-2 sandwich 
ELISA kit, according to the manufacturer's protocol (R&D Systems; Minneapolis, 
MN). For evaluating DNA content, the cells cultured in monolayer were washed 
in PBS, placed in digestion buffer (10 mM Tris, 1 mM EDTA, and 0.1% Triton X-
100 with 0.1 mg mL−1 proteinase K, Sigma-Aldrich) in centrifuge tubes, and 
incubated overnight at 50 °C. The supernatants were sampled, the Picogreen 
dye (Molecular Probes, Eugene, OR) was added to the samples in 1 : 1 ratio, and 
read in fluorescent plate reader at excitation of 485 nm, emission of 528 nm 
(BioTek, Winooski, VT). A standard curve was prepared from a solution of 
salmon testes DNA (Molecular Probes).  
 
3.3.3 Alkaline phosphatase (AP) measurement and staining 
For alkaline phosphatase (ALP) measurement, cells were harvested in 100 µL of 
lysate buffer consisting of PBS (Fisher), 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate, 0.1 mg mL−1 
phenylmethylsulfonylfluoride (PMSF) and 3% aprotinin (Sigma-Aldrich), that was 
maintained on ice and vortexed intermittently for 30 min to break down the cell 
membranes. The extracts were removed, centrifuged and the supernatants were 





and 50 µL nitrophenyl-phosphate substrate solution (Sigma-Aldrich) in micro-
centrifuge tubes at 37 °C for 10–20 min. The reaction was stopped with 0.5 N 
NaOH (Sigma-Aldrich). The absorbance was read at 405 nm (Molecular Devices, 
Sunnyvale, CA) and compared to a standard curve obtained from p-nitrophenol 
solutions (Sigma-Aldrich) of known concentrations. For ALP staining, the cultured 
cell monolayer was fixed in citrate buffered acetone for 30 s, after rinsing in 
distilled water for 45 s, and the fixed monolayer was immersed into alkaline-dye 
mixture consisting of 4% AS-MX Phosphate Alkaline solution in diluted diazonium 
salt solution (Sigma-Aldrich), for 30 min in dark, and washed in de-ionized water. 
ALP staining was captured by microscope (Olympus IX81, Center Valley, PA).  
 
3.3.4 Calcium measurement and von Kossa staining 
For calcium measurement, the cells were extracted by 5% trichloroacetic acid 
(Sigma-Aldrich), and diluted as necessary to be within tolerance ranges of assay. 
Ocresolphtalein complex was added (Calcium CPC LiquiColor Test, Stanbio 
Laboratory, Boerne, TX) and the calcium content was measured in 
spectrophotometer at 550 nm (Molecular Devices). For von Kossa staining, the 
cultured cells monolayers were washed with PBS and fixed in cold 10% buffered 
formalin (Fisher). The cells were then rinsed by distilled water and then 
immersed in 5% silver nitrate (Sigma-Aldrich) solution followed by exposure to 







3.3.5 Bone sialoprotein (BSP) staining 
For BSP staining, cell monolayers were washed with PBS and fixed in cold 10% 
buffered formalin (Fisher). The cells were then rinsed by distilled water quenched 
with 0.3% H2O2, and blocked with PBS containing 5% BSA and 0.02% (vol/vol) 
goat serum (Sigma-Aldrich) for 30 min at room temperature. After rinsing with 
PBS, slides were incubated with 1 : 1000 BSP antibody (Sigma-Aldrich) overnight. 
The fixed cells were washed with PBS and incubated with biotinylated goat anti-
rabbit serum (Sigma-Aldrich) and Vectastain ABC Kit (Vector Laboratories, 
Burlingame, CA) for 30 min at room temperature. Brown color was developed 
with SIGMAFAST diaminobenzidine (Sigma-Aldrich) for 10 min at room 
temperature. Slides were then counter-stained with hematoxylin (Sigma-Aldrich).  
 
3.3.6 Design and manufacture of fluidic systems 
3.3.6.1 Flow channel 
A microfluidic flow channel (Figure 3.2B) was fabricated by using standard soft 
lithography methods. Photo-masks with channel patterns were designed using 
AutoCAD (AutoDesk, San Rafael, CA), and printed on transparencies with 
20 000 dpi resolution. Master molds patterned with 100 µm thick resist were 
made by patterning a negative photoresist on a silicon wafer (manufactured by 
Stanford Microfludics Foundry). PDMS molds were fabricated by curing 
prepolymer (Sylgard 184, Essex Chemical, Midland, MI) on silicon masters 
patterned with SU-8 photoresist. Briefly, PDMS prepolymer composed of 





was patterned with photoresist and cured at 60 °C for 2 h. The PDMS molds 
were peeled off the silicon wafer. The inlet and outlet of the micro channel were 
created by a sharp punch (1 mm diameter, Fisher) for medium perfusion and cell 
seeding. The complete microfluidic device consisted of a top PDMS fluidic 
channel, a bottom glass slide, tygon tubing (0.79 mm inside diameter (ID), 2.38 
mm outside diameter (OD), McMaster, Robbinsville, NJ), stainless steel tubing 
(0.64 mm ID, 0.81 mm OD, McMaster) and syringe pump (Harvard Apparatus, 
Boston, MA). The main fluidic channel was 100 µm high × 20 mm long × 6 mm 
wide, and the branches were 100 µm high × 10 mm long × 3 mm wide. The 
microfluidic layer was bonded to oxygen plasma treated glass slide (Harrick 
Scientific, Pleasantville, NY), with channels at the top, slide at the bottom).  
 
3.3.6.2 Flow experiments 
The flow channel was sterilized by overnight exposure to 70% ethanol and UV 
light. Tubing was sterilized separately. The channels were coated with 10 µg ml−1 
of fibronectin for 2 h, and let dry. A suspension of C9 cells was loaded into the 
channel (150 µL of suspension, at 1 × 105 cells mL−1) and incubated overnight in 
a 37 °C/5% CO2 humidified incubator. In this case, the cells formed a confluent 
monolayer. Prior to the experiment, the flow channel was connected to a syringe 
pump via tubing that was primed with proper culture medium, and the output 






For dye separation experiments, cells were subjected to 2 continuous streams of 
flow for 30–60 min, with one stream of media containing 2 µM Calcein-AM, and 
the other stream of unsupplemented medium. The stream with Calcein-AM was 
subsequently replaced with unsupplemented medium for a 30 min wash. For 
osteogenic differentiation experiments, cells were continuously perfused in 
differentiation medium, with 1 ng ml−1 or 0 ng ml−1 Dox for 3 weeks. 
 
3.3.7 Mathematical model 
3.3.7.1 Velocity and shear stress profiles  
The channel geometry was selected to permit calculation of the wall shear stress 








where µ is the fluid viscosity and ρ is the fluid density, Q is the fluid flow rate, w 
and h are the width and height of the channel/chamber. The hydrodynamic 
development length L in a channel of a height h can be estimated as (Atkinson et 










3.3.7.2 Computational model 
A computational model based on finite element method (COMSOL Multiphysics 
v3.2, Burlington, MA) was used to simulate the concentration and velocity profiles 
in the channel/chamber. The concentration gradient could be described by 3D 




  ∇u = 0 (5) 




where ρ, u, and p are the density, flow velocity and pressure of the liquid, 
respectively, and C and D are the concentration and diffusivity of the molecules. 
At each time step, the flow velocity was first calculated independently, and the 
concentration was then determined for the computed flow. The boundary 
conditions were as follows. At the inlet, flow velocity was set according to the 
specific experiment. At the outlet, we imposed zero normal stress. At the channel 
walls, we imposed the no-slip condition, and no flux condition. For the 









3.3.8 Image analysis 
The sequential images were acquired using an inverted microscope (Olympus 
IX81), stored, assembled and analyzed digitally by Photoshop CS4 program 
(Adobe, San Jose, CA). For quantitative analysis of calcium deposition staining, 
the assembled color images were converted to black and white images, and the 
brightness and darkness of the images were inverted, to capture the dark stain of 
calcium deposition. Calcium deposition was quantified from ratio of the 
normalized sum of segmented image intensity and the minimum segmented 
image intensity, moving along the width of the channel/chamber, and using the 
Matlab R2007 program (Matlab, Natick, MA).  
 
3.3.9 Statistics/data analysis 
Data were expressed as mean ± standard deviation (SD) of the measured values. 
Data were analyzed by ANOVA for multiple comparisons, and a post hoc test for 
group to group comparisons, with P < 0.05 considered statistically significant. 
 
3.4 Results 
3.4.1 Regulation of BMP-2 expression and osteogenic differentiation in static 
culture 
We first characterized the Dox-dependent BMP-2 secretion and Dox-dependent 
osteogenic differentiation in static culture, for a series of Dox concentrations (0–
1000 ng ml−1, Figure 3.3). For C9 cells grown in static culture, secretion of BMP-





<1 ng ml−1. The amount of secreted BMP-2 in medium was negatively correlated 
to the concentration of Dox, and reached ther maximum level when Dox was 
absent from medium. During 4 weeks of osteogenic differentiation, BMP-2 was 
mostly secreted within the first 2 weeks of culture, after which the secretion of 
BMP-2 significantly decreased, possibly due to the decrease in cell metabolism 
with time in culture. When Dox concentration was ≥1 ng ml−1, BMP-2 secretion 
could not be detected by ELISA throughout the culture period (Figure 3.3A). The 
DNA measurements of the C9 cells showed that the variation of Dox 
concentration from 1000 ng ml−1 to 0 ng ml−1 had no significant effect on cell 
proliferation in the osteogenic-inductive culture (Figure 3.3B). 
The Dox concentrations in the range 1 ng ml−1 to 0 ng ml−1 induced Dox-
dependent expression of BMP-2 that in turn induced BMP-2-dependent 
osteogenic differentiation of C9 cells, as evidenced by calcium deposition and 
expression of ALP (Figure 3.3C–F). Calcium measurement and von Kossa 
staining showed no detectable calcium deposition until the 3rd week of static 






Figure 3.3  Characterization of inducible BMP-2 expressing cell line (C9) (A) 
ELISA measurement of the secreted BMP-2 in culture media (n = 3). (B) C9 cell 
proliferation profile by DNA measurement (n = 6). (C) Measurement of Calcium 
deposition (n = 4). (D) Measurement of alkaline phosphates (AP) (n = 4). *: p < 0.05. **: 
p < 0.05. (E) von Kossa staining of the C9 cells. (F) AP staining of the C9 cells. Original 





had significantly higher deposition of calcium than C9 cells cultured at higher Dox 
concentrations (≥1 ng ml−1) in weeks 3–4 of culture (Figure 3.3C and E). 
Consistently, the ALP expression in cells cultured at low Dox concentrations (0 or 
0.1 ng ml−1) was high after one week of osteogenic induction culture (Figure 
3.3D and F), demonstrating the initiation of osteogenic differentiation. 
 
In summary, the in vitro static culture suggested strong correlations between Dox 
concentration, BMP-2 secretion and osteogenic differentiation. These BMP-2 
induced cells exhibited a clear “cutoff” of BMP-2 expression and osteogenic 
differentiation at Dox concentration of 1 ng ml−1, and the differentiation was 
detectable after 3 weeks of culture. Based on these findings, in subsequent flow 
experiments we used bi-laminar flows of CDox = 1 ng ml
−1 and CDox = 0 ng ml
−1 to 
generate osteoblast–fibroblast interface in the same construct. 
 
3.4.2 Characterization of the flow channel 
The velocity profiles and concentration profiles in the device were analyzed in 
detail using COMSOL Multiphysics®. Firstly, the flow and mixing in the fluidic 
channel were determined. In order to generate a concentration interface 
perpendicular to the flow inside the channel, it was necessary that the flow past 
the inlet tubes be fully developed and laminar.  
 
The flow was characterized by low Reynolds numbers, of 0.055–0.011 for the 





of 5 µl min−1 × 2 corresponded to Re = 0.055 and the hydrodynamic development 
length of 32 µm in the flow channel. Thus, the flow in each system could be 
considered as fully developed, with negligible variation in the direction transverse 
to flow. The wall shear stress in the cell culture zone was 16.7–3.3 mPa. 
 
Figure 3.4  Flow analysis Simplified flow model, the steady-state velocity and 
concentration profiles are shown for a flow rate of 1 µl min−1 × 2. Data were calculated 
for the diffusion coefficient DDox = 3.93 × 10
−6 cm2 s−1, fluid viscosity ν = 10−3 Pa s, fluid 
density ρ = 103 kg m−3, and inlet concentrations CDox = 1 ng ml
−1 = 2.25 × 10−12 mol ml−1 
and CDox = 0 ng ml
−1. 
 
Simplified fluidic models were developed to study the flow and concentration profiles at 
steady state (Figure 3.4). Different values of the flow rate were simulated, while 
maintaining at constant levels the other parameters, such as diffusion coefficient (DDox = 
3.93 × 10−6 cm2 s−1) (Wilke and Chang, 1955), flow viscosity (ν = 10−3 Pa s), fluid density 
(ρ = 103 kg m−3) and input concentrations (CDox = 1 ng ml
−1 = 2.25 × 10−12 mol ml−1; CDox 
= 0). Simulation showed that two fluid flows meet in the device, creating a concentration 







Figure 3.5 Dye separation studies Separation of Calcein stain in the flow channel 
at the flow rates of 5 µl min−1 × 2 (A) and 1 µl min−1 × 2 (B). Data are for the diffusion 
coefficient of Calcein DCalcein = 2.6 × 10
−6 cm2 s−1, and inlet concentrations of Calcein C+ 
= 2 µM and C− = 0, diffusion coefficient of Trypan blue of DTrypan blue = 2.21 × 10
−6 cm2 s−1, 
and input concentrations of Trypan blue of C+ = 229 µM and C− = 0. Flow direction is left 
to right. Original magnification: 100×. Scale bar: 1 mm.  
 
To visualize the concentration profiles in each of the fluidic systems, Calcein-AM, 
(DCalcein = 2.6 × 10
−6cm2 s−1) was used as a model molecule, and the fluorescent 
images were acquired to show selective Calcein distribution only in cells within 
the channel (Figure 3.5). The concentration profiles were additionally verified in 
experiments that used the trypan blue dye (Dtrypan_blue = 2.29 × 10
−6 cm2 s−1). In 
summary, the patterned Calcein/Trypan blue distribution verified the simulation 
result, indicating that the bi-laminar-fluidic system permitted the alignment of two 





3.4.3 Patterning of osteogenic differentiation 
We examined the effect of patterning Dox concentration on osteogenic 
differentiation. Mineral deposition within cell culture constructs was analyzed 
after 3 weeks dynamic culture in osteogenic differentiation media as a functional 
marker of osteogenesis. The result showed C9 cells cultured with continuous 
Dox (1 ng ml−1) treatment displayed less mineral deposits (Figure 3.6A1 and A2), 
whereas C9 cells cultured without Dox treatment displayed more and relatively 
uniform mineral deposits (Figure 3.6C1 and C2). C9 cells cultured in a gradient 
of Dox concentration exhibited zonal organization of mineral deposition (Figure 
3.6B1 and B2). By pooling together the independent experiments, and 
quantifying the normalized intensity of mineralization in the flow chamber, we 
observed a gradual decrease in mineralization across the Dox 0 ng ml−1 and Dox 
1 ng ml−1 interface (Figure 3.6B3), that was not observed at continuous Dox 
concentrations of 1 ng ml−1 ((Figure 3.6A3), or 0 ng ml−1 (Figure 3.6C3). 
However, we also observed some scattering of mineralization across the 
interface, and close to edge areas, possibly due to molecular diffusion of Dox, 








Figure 3.6 Dox dependent osteogenic differentiation in the flow channel. C9 cells 
were cultured in osteogenic differentiation medium in a perfused flow channel, at a flow 
rate of 1 µl min−1 × 2, for 3 weeks. Images show von Kossa staining of calcium 
deposition for selected conditions: (A1, A2) Perfusion medium with Dox 1 ng ml−1 (top)/1 
ng ml−1 (bottom); (B1, B2) Perfusion medium: Dox 0 ng ml−1 (top)/1 ng ml−1 (bottom); (C1, 
C2) Perfusion medium: Dox 0 ng ml−1 (top)/0 ng ml−1 (bottom). (A3, B3, C3) Intensity of 
calcium staining, obtained by pooling repeated experiments (n = 3 per condition). The 
staining of the deposited calcium is expressed at the ratio of the normalized sum of 
segmented ( 0.25 mm) image intensity and the minimum intensity along the y axis (the 
width) of the chamber. Data were processed using Matlab R2007 program. Flow 
direction: left to right. Scale bar: 1 mm 
 
 
After the flow channel was scaled up to the fluidic chamber (Supplemental 
Figure 3.1), we successfully replicated the computational simulation of the fluidic 
profiles, the dye separation test (Supplemental Figure 3.2), and the patterning 
of osteogenc differentiation (Supplemental Figure 3.3). 
 
We observed significant effects of medium flow rate on osteogenic differentiation. 
Under high flow rate at 5 µl min−1 × 2 in fluidic channel (Supplemental Figure 
3.4A), or 8 µl min−1 × 2 in fluidic chamber (Supplemental Figure 3.4B), the C9 
cells exhibited a less differentiated phenotype, compared to the cells cultured at 
a flow rate of 1 µl min−1 × 2 in fluidic channel (Figure 3.6), or 4 µl min−1 × 2 in 
fluidic chamber (Supplemental Figure 3.3). Osteogenic differentiation was 





(Supplemental Figure 3.4C). These effects were likely due to the dilution of cell-
secreted factors (such as BMP-2) at higher medium flow rates. 
 
We were not able to generate an uniform gradient of ALP staining along the Dox 
concentration profile. In contrast, we observed a clear pattern of distribution of 
bone sialoprotein, a major component of the bone extracellular matrix, that 
followed the pattern of Dox concentration, both in flow channel and flow chamber 
(Supplemental Figure 3.5B and C). In addition, we observed relatively uniform 
distribution of cells after 3 weeks fluidic culture (Supplemental Figure 3.5A). 
Taken together, these results demonstrate that spatial control over Dox 
distribution can lead to spatial control over BMP-2 expression, and spatial control 
over osteogenic differentiation. 
 
3.5 Discussion 
We explored a novel strategy to patterning osteogenic differentiation to generate 
a stable interface between differentiated and undifferentiated cells. Osteogenic 
differentiation was patterned by BMP-2 gene expression, which in turn was 
patterned by the BMP-2 modulator Dox, using a bi-laminar microfluidic system. 
This strategy of patterning the expression of key master regulator genes within 
tissues mimics the mechanisms of the development that underlie patterned 
differentiation in vivo (Seris et al., 2005). Previous gene expression and 
immunohistochemical studies described distribution and localization of BMP-2 





with the known effect of BMP-2 gradients on osteogenesis. BMP-2 gradients 
were also implicated in chondrogenic differentiation in the growth plate (Nilsson 
et al., 2007) and in pituitary organogenesis (Treier et al., 1998). The formation of 
BMP-2 gradients thus provides an interesting approach for application in tissue 
engineering.  
 
Characterization of the C9 cells with inducible BMP-2 gene expression in static 
culture showed that BMP-2 secretion was tightly controlled by Dox concentration. 
The C9 cells had clear “cutoff” of BMP-2 secretion at Dox of 1 ng ml−1. In the 
range of Dox concentrations of 1 ng ml−1 to 0 ng ml−1, the cells showed Dox-
dependent BMP-2 secretion, leading to BMP-2-mediated osteogenic 
differentiation, that was clearly evidenced by calcium deposition and ALP activity. 
Therefore, by coupling the Dox-dependent BMP-2 secretion and BMP-2-
dependent osteogenic differentiation, we were able to directly control osteogenic 
differentiation by the gene expression modulator, Dox. Notably, Dox is a simple 
semi-synthetic tetracycline (molecular weight of 444), widely used to treat a 
variety of infections (Sweet et al., 1988), which could provides a cost-effective 
and efficient “turn on”–“turn off” functions for engineering tissue functionality. The 
“turn on”–“turn off” functions of the inducible gene expression could be further 
used in a temporary manner, and adapted to study the dynamics of gene 






The microfluidic channel designed to conduct the present study is a simple 
device with two parallel laminar flow streams. The computational simulation and 
dye separation studies confirm that this microfluidic system can be used to create 
distinct regions of constant concentration and form time-invariant gradients 
across the cell culture area, due to the lack of convective mixing under low-Re 
number laminar flow. After 3 weeks of cell culture with perfusion that generated a 
patterned delivery of Dox, we observed patterned osteogenic differentiation that 
correlated to the pattern of Dox concentration. In the microfluidic chamber, after 3 
weeks of osteogenic differentiation, a transient gradient of mineral deposition, 
with high calcium deposition at the top and low calcium deposition at the bottom, 
was established, in response to the Dox concentration profiles. 
 
Compared to the fluidic channel, the fluidic chamber offers additional flexibility. 
First, it allows the cells to be attached to a glass slide before the chamber 
assembly, which can provide better control of cell seeding and distribution, a 
feature suitable to a variety of cell culture applications. Second, as the length of 
the flow chamber is increased, more mixing may occur via diffusion 
perpendicular to the direction of fluid flow, while keeping input flow rates and 
compositions constant. Therefore, we were able to create and maintain a range 
of gradients by carefully choosing the concentrations and flow rates of the fluid 
streams, for long periods of time. This feature may enable studies of more 
sophisticated cell functionality in response to gradients of signals. Third, the 





gasket, thereby adjusting shear stress in the system. Potentially, the microfluidic 
chamber could be eventually up-graded to hold slim 3-dimensional tissue 
constructs for study of higher order tissue interfaces. 
 
In laminar-fluidic systems, the paracrine/autocrine signals released by the cells in 
response to the applied gradient could be quickly removed by medium perfusion 
and accumulated downstream. In this study we observed that flow diluted the 
extracellular concentration of BMP-2, leading to “less differentiated” phenotype 
compared to static culture. These effects could be modulated to some extent by 
adjusting the flow rates. By decreasing the flow rates, from 8 µl min−1 × 2 to 4 µl 
min−1 × 2 in fluidic chamber, or from 5 µl min−1 × 2 to 1 µl min−1 × 2 in fluidic 
channel osteogenic differentiation was markedly enhanced calcium deposition. 
We also observed that the osteogenic differentiation increased at the channel 
walls, presumably due to the edge effects in laminar flow system. In a typical 
laminar flow profile, the highest velocity is found in the center of channel or 
chamber, while the lowest velocity (V = 0) is found along the wall. As discussed 
above, osteogenic differentiation is enhanced at lower fluid flow rates. Therefore, 
the zero velocity along the wall can lead to the accumulation of autocrine and 
paracrine signals, and result in a higher degree of osteogenic differentiation even 
with the presence of Dox. Therefore, we suggest that the analysis of cell 






In summary, we developed an interface between osteogenic and undifferentiated 
cells, as a prototype of our proposed patterned gene expression strategy. The 2D 
system investigated in this study presents a valuable tool for controlled in viro 
study of osteogenesis. 
 
Patterned osteogenesis of mesenchymal stem cells, when scaled up to 3D, 
would enable generation bone-ligament or osteo–chondrogenic interface in 
engineered tissue constructs. Future work of interest includes patterning of 
osteogenesis–fibrogenesis interfaces, by modulation of inducible BMP-2 
expression on one side of the interface, and modulation of other growth factors 
(Lee et al., 2010) (connective tissue growth factor, CTGF, and TGF-beta1) on the 
other side of the interface, using the fluidic chamber. Likewise, osteogenic–
chondrogenic interface could be patterned by constructing a super vector 
composed of two gene expression cassettes—inducible BMP-2 expression under 
Tet-on promoter and inducible Sox9 under RheoSwitch promoter. Such a vector 
would mimic a biological circuit controlling the expression of two separate genes 
(BMP-2 and Sox9) with combination of modulators. 
 
3.6 Conclusion 
In summary, this study demonstrates that a continuous, graded osteogenesis 
tissue interface can be established by patterning the BMP-2 gene expression, via 
patterning of the BMP-2 modulator Dox, using a simple laminar-fluidic system. 





for enhanced tissue integration and biological function. The technology also 
provides an interesting model to study how a gradient of gene expression can 
modulate cell fate and expression of a specific phenotype or function. The use of 
alternative cell types and 3-dimensional scaffolds could enable regeneration of 
more sophisticated, higher-order tissue interfaces that mimic the structural and 
functional characteristics of native tissues. 
 
3.7 Supplemental Information 
 
Supplemental figure 3.1  Flow chamber The flow chamber consisted of a 1mm 
thick borosilicate glass plate glued into the bottom of a uniformly deep groove milled into 
a Plexiglas block, and another glass slide with pre-seeded cells. The two plates were 
held together with screws and a Plexiglas lid, separated by a uniform thickness 
rectangular silastic spacer (McMaster). As a result, a flow chamber (5.2 cm long x 1.2cm 
wide x 154>m high) was created. Flow inlets and outlets were connected to cylindrical 
reservoirs in the Plexiglas block. A 2mm thick borosilicate glass blocked each of the 
cylindrical reservoirs in the middle, and separated the flows to and from the two ports. 
Plastic tubing (high-temperature silicone rubber soft tubing, 1.59mm ID, 3.18mm OD, 
McMaster) connected the inlet port to one-direction syringe pump (Harvard) and the 







Supplemental figure 3.2  Characterization of flow chamber (A) Simplified flow 
models, the steady-state velocity and concentration profiles are shown for the flow 
channel at flow rate of 4µl/min x2. Data were calculated for the diffusion coefficient 
DDox=3.93x10
-6cm2/s, fluid viscosity ν=10-3Pa*s, fluid density ρ=103kg/m3, and inlet 
concentrations CDox=1ng/ml= 2.25x10
-12mol/ml and CDox=0ng/ml=0. (B) Separation of 
Calcein stain in the flow channel at the flow rates of 4µl/min x2. Data are for the diffusion 
coefficient of Calcein DCalcein=2.6*10-6cm2/s, and inlet concentrations of Calcein 
C+=2µM and C-=0, diffusion coefficient of Flow direction is left to right. Original 







Supplemental figure 3.3  Dox dependent osteogenic differentiation in flow 
chamber C9 cells were cultured in osteogenic differentiation medium in a perfused flow 
chamber, at a flow rate of 4µl/min x2, for 3 weeks. Images show von Kossa staining of 
calcium deposition for selected conditions: (A1, A2) Perfusion medium with Dox 1ng/ml 
(top) / 1ng/ml (bottom); (B1, B2) Perfusion medium: Dox 0ng/ml (top) / 1ng/ml (bottom); 
(C1, C2) Perfusion medium: Dox 0ng/ml (top) / 0ng/ml (bottom). (A3, B3, C3) Intensity of 
calcium staining, obtained by pooling repeated experiments (n=4 per condition). The 
staining of the deposited calcium is expressed at the ratio of the normalized sum of 
segmented (~0.25mm) image intensity and the minimum intensity along the y axis (the 
width) of the chamber. Data were processed using Matlab R2007 program. Flow 







Supplemental figure 3.4  The effect of flow rate to osteogenic differentiation (A) 
von Kossa staining of the fluidic channel, at flow rate of 5µl/min x2. Perfusion medium: 
Dox 0ng/ml (top) / 1ng/ml (bottom); (B) von Kossa staining of the fluidic channel, at flow 
rate of 0.5µl/min x2. Perfusion medium: Dox 0ng/ml (top) / 0ng/ml (bottom); (C) von 
Kossa staining fragment of the fluidic chamber, at flow rate of 8µl/min x2. Perfusion 







Supplemental figure 3.5  Cell distribution and BSP staining (A) Phase contrast 
image of cell distribution in fluidic channel after 3 weeks osteogenic differentiation at flow 
rate of 1µl/min x2. Perfusion medium: Dox 0ng/ml (top) / 1ng/ml (bottom). (B) BSP 
staining of the cells after 3 weeks patterned osteogenic differentiation in fluidic channel 
at flow rate of 1µl/min x2. Perfusion medium: Dox 0ng/ml (top) / 1ng/ml (bottom). BSP 
staining of the cells after 3 weeks patterned osteogenic differentiation in fluidic chamber 
at flow rate of 4µl/ml x2. (C) Perfusion medium: Dox 0ng/ml (top) /1ng/ml (bottom); (D) 
Perfusion medium: Dox 1ng/ml (top) / 1ng/ml (bottom); Flow direction: left to right. 
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Chapter 4 Patterning embryonic cell pluripotency by inducible Nanog 
expression in multi-laminar fluidic system 
 
4.1 Abstract 
During native tissue development and remodeling, the differentiating cells self-
organize into multicellular domains, forming boundaries and interfaces, in 
response to spatial gradients of signals. Deciphering how this transformation 
occurs and regenerating these transitional zones in vitro remains a significant 
challenge. By combining inducible gene expression with laminar flow 
technologies, we developed a strategy to pattern gene expression in cultured 
cells, along with forming gradients of soluble factors. Using Nanog safeguarded 
embryonic pluripotency as a model, we patterned Nanog expression, and thereby 
patterned early differentiation status under the exposure or withdrawal of small 
molecules, as evidenced by the analysis of genes and proteins. By this strategy, 
we successfully developed controllable differentiation – pluripotency boundaries 
between Nanog expressing (pluripotency) zone and Nanog suppressed (early 
differentiation) zone from the same population of cells, to mimic some aspects of 
development. By using this approach, mechanistic insights can be gained on 
dissecting the signaling pathways that drive multicellular patterning during 









Embryonic stem cell (ESC) lines maintain on a long-term their self-renewal 
capacity and the capacity to differentiate into cells of all three germ layers. Cell 
fate choices are regulated by a complex orchestration of transcription factors 
Oct4, Sox2, Nanog as well as the LIF-gp130-Stat3, BMP-TGF-beta-Smad, 
MAPK-ERK, and possibly the WNT signaling pathways (Nichols et al., 1998; 
Niwa et al., 2000; Chambers et al., 2003; Mitsui et al., 2003; Niwa et al., 1998; 
Ying et al., 2003; Burdon et al., 1999; Sato et al., 2004).  The spatial control of 
these signals and the arrangement of stem and differentiation cells lead to highly 
organized structure and graded tissue interface or boundaries in embryonic 
development, which play central role in organ development and function. Over 
the past few decades, evidence accumulated to support a model for the 
patterning of cells. This model, known as the French Flag model, describes how 
a signal gradient across the field is converted into gene expression domains by 
the concentration specific response of target genes (Wolpert, 1969).  Boundaries 
are formed between these different gene expression domains, where interaction 
between these different types of cells leads to form secondary signaling centers 
and more sophisticated local patterns (Meinhardt, 1983).   Thereby it is critical to 
recapitulate these tissue interfaces and boundaries in studies of native and 
engineered tissues. 
 
Based on current engineering technologies, precise spatial patterns of 





proteins (Monier et al., 2010, Landsberg et al., 2009), and by patterning the 
soluble and adhesive biological factors (Singh et al., 2008; Dormer et al., 2010).  
Only a few efforts have focused on direct patterning of gene expression at the 
transcriptional level, for control of downstream cellular function. In a previous 
study, we have developed a novel engineering strategy which for direct 
patterning and modulation of gene expression at transcriptional level in a two-
dimensional field of cultured cells, by regulating the presence of modulators of 
inducible gene expression (Zhang et al., 2011). Using the inducible BMP-2 gene 
expression as a model, we demonstrated that a continuous, graded osteogenesis 
tissue interface can be established by patterning the BMP-2 gene expression, via 
patterning of the BMP-2 modulator doxycycline (Dox), in a simple microfluidic 
system.  
 
In this study we developed a strategy to study a single genetic perturbation in 
hESCs (Figure 4.1).  We used mouse ESC Nanog rescue clone (NanogR) 
(Ivanova et al., 2006) which is an inducible lentiviral-based complementation 
system. In this lentiviral system, a short hairpin RNA (shRNA) depletes 
endogenous Nanog mRNA, and normal levels of Nanog can be restored in a 
doxycycline-dependent manner for a shRNA ‘immune” version (Figure 4.1A). As 
Nanog plays a central role in embryonic stem cell fate, safeguards pluripotency 
by reversing / resisting nascent epigenetic modification (Chambers et al., 2007; 
Lu et al., 2009). By patterning Nanog expression in multiple-laminar fluidic 





renewal and early commitment towards differentiation. This strategy can provide 
a platform to engineer and analyze the boundaries of different gene expression 
domains in a wide range of culture conditions, and to study how intrinsic / 
exogenous signals consolidate into differentiation commitment decisions. 
 
Figure 4.1  Cell model and experiment Scheme (A) Scheme of inducible Nanog 
expression in a Dox dependent manner. Without Dox, shRNA depletes endogenous 
Nanog mRNA, which leads to Nanog mediated cell differentiation in the presence of 
proper differentiation signals; with Dox, inducible exogenous Nanog gene expression 
under the control of inducible Tet-on expression system, restore the normal levels of 
Nanog expression. (B1, B2) Experiment outline: cultured NanogR cells are exposed to 
laminar fluidic flows with two streams (one pluripotency [P] stream contains both Dox 
and LIF, in align with another P stream, a differentiation [D1] stream contains LIF, a 
differentiation [D2] stream contains no LIF, or a differentiation [D3] stream contains RA). 
(C1) Flow chamber (main chamber: 52mm L x 12mm W x 0.154mm H). (C2) Simulated 
fluidic profiles (flow rate v=4µl x2/min) in simplified flow model. (C3) Simulated Dox 
concentration profiles at P:D1, P:D2, P:D3 conditions in steady status. (C4) Simulated 
LIF concentration profiles at P:D2, P:D3 conditions in steady status. (C5) Simulated RA 
concentration profiles at P:D3 condition in steady status. Input concentration: Dox: 
500µg/ml=1.13x10-9[mol/ml]; LIF: 103units/ml=2.13x10-13[mol/ml]; RA: 5µM=5x10-










First, we characterized the inducible Nanog expression in the Nanog rescue 
clone (NanogR) in static culture, titrated with varied differentiation conditions: (i) 
LIF supplemented mouse ESC (mESC) maintenance media, (ii) LIF free mESC 
maintenance media, and (iii) LIF free and Retinoic Acid (RA) supplemented.  We 
assayed a Dox dosis respond (0ng/ml-1000ng/ml) for Nanog expression levels in 
all different culture conditions verified by both immunological staining and real 
time PCR.  The Dox concentration depended Nanog expression lead to Nanog 
concentration depended differentiation, verified by alkaline phosphatase (AP) 
staining and gene expression analysis. Then in the flow experiments, we 
successfully patterned the pluirpotency zone with sustained Nanog expression in 
alignment with different differentiation zones by patterning Dox / LIF / RA in the 
fluidic system.  We demonstrated the pattern of pluripotency and differentiation 
can be achieved in the same population of cells at an individual colony level.  
 
4.3 Materials and Methods 
4.3.1 Embryonic stem cell culture and differentiation 
The murine Nanog inducible expression mESC cell line (NanogR) was developed 
from mouse embryonic stem cell line Aniv15 that contains the transactivator (rtTA, 
TetOn) by infection with the lentiviral that contains a Nanog short hairpin RNA 
(shRNA), which depletes endogenous Nanog mRNA, and under the control of 
inducible Tet-on expression system is cloned the coding region of the genes, 
which can restore the normal levels of Nanog expression in a doxycycline 





The NanogR cells were maintained on primary mouse irradiated embryonic 
fibroblasts (pMEFs) in the DMEM media supplemented with 15% FBS (Hyclone), 
100 mM MEM nonessential amino acids, 0.1 mM 2-mercaptoethanol, 1 mM L-
glutamine (Invitrogen), 100 U/ml penicillin, 100mg/ml streptomycin, 1 mM sodium 
pyruvate and 103 units/ml of LIF (Chemicon). For experiment assays, NanogR 
cells were cultured on 0.1% gelatin-coated tissue culture plates without pMEFs. 
To induce differentiation, we withdrew doxycycline (1 µg ml-1) from the media, 
and maintained cells in LIF containing, LIF free, or LIF free plus Retinoic Acid 
(5µM) media.  All cell cultures were maintained at 37ºC with 5% CO2. 
 
4.3.2 Alkaline phosphatase staining 
Alkaline phosphatase (AP) activity was measured using a commercial detection 
kit (Sigma-Aldrich). The cultured cells were fixed in 4% paraformaldehyde in PBS 
for 2 minutes. After washed with TBST (20mM Tris-HCL, pH7.4, 0.15M NaCl, 
0.05% Tween-20), the fixed cells were immersed into alkaline-dye mixture 
consisting of fast red violate, Napthol phosphate solution and water in 2:1:1 ratio, 
for 20minutes in darkness (or 7 minutes when staining flow experiment samples), 
and were washed in TBST again. ALP staining images was captured by 
microscope (Olympus IX81, Center Valley PA).  
 
4.3.3 Real-Time (RT) PCR 
For gene expression analysis, total RNA was TRIzol® -extracted (Invitrogen), 





transcribed using high capacity reverse transcription kit (Applied Biosystems). All 
quantitative PCR analyses were performed using the Fast SYBR® Green Master 
Mix (Applied Biosystems) following manufacturers’ protocol on the 
LightCycler480 Real-Time PCR System (Roche). Each PCR reaction generated 
a specific amplicon, as demonstrated by melting-temperature profiles of final 
products (Dissociation Curve analysis). No PCR products were observed in the 
absence of template. In gene expression analysis, all data were normalized to 
beta-actin. Gene-specific primers used for amplification are listed in 
Supplemental Table 4.1. 
 
4.3.4 Immunofluorescent staining 
Cells cultured at different Doxycycline concentrations and at the respective days 
0, 1, 3 and 5 were rinsed twice with PBS, fixed with 4% paraformaldehyde in 
PBS 1X for 20 min at room temperature, quenched with 0.2M glycine in PBS 1X 
for 10 min, permeabilized with PBS containing 0.5% Triton X-100 for 30 min. 
Nonspecific sites were blocked by incubation with PBS containing 0.1% BSA for 
30min at room temperature. Cells were then incubated with the specific primary 
antibodies: 1:100 anti-mouse Oct4 (Santa Cruz), or 1:150 anti-mouse Nanog 
(Cosmo Bio), diluted in PBS 1X containing 0.2% Triton X-100 and 0.1% of BSA 
for overnight incubation at 4 degree. After that, cells were incubated with one of 
the following secondary antibodies: Alexa Fluor® 546 donkey anti-goat 
(Invitrogen) (1:1000 dilution) and Alexa Fluor® 488 donkey anti-rabbit IgG 





X-100 for 3 times, the samples were incubated for 5 minutes with 1:1000 DAPI in 
water, followed by wash with PBS 1X containing 0.2% Triton X-100 for 3 times.  
We observed the complete loss of GFP three days after fixation (Supplemental 
Figure 4.1), to avoid GFP signal contamination in immune-fluorescence staining, 
the staining was completed and fluorescence images were captured three days 
after fixation with a Nikon Eclipse TE 2000-U or Olympus BX41 fluorescent 
microscope.  
 
4.3.5 Design and manufacture of the microfluidic systems  
4.3.5.1 Flow chamber 
The flow chamber (Figure 4.1) consists of a 1mm thick borosilicate glass plate 
glued into the bottom of a uniform depth groove milled into a Plexiglas block and 
another glass slide with pre-seeded cells. The two plates are brought together 
with screws and a Plexiglas lid, separated by a uniform thickness rectangular 
silastic spacer (McMaster) creating a flow chamber which is 5.2 cm, 1.2 cm, 
154µm (length, width, and height or gap distance). Flow enters / exits the 
chamber from two ports of the cylindrical reservoirs into/out of the Plexiglas block. 
A 2mm thick borosilicate glass blocks each of the cylindrical reservoirs in the 
middle, which separate the flows from /to two ports. Plastic tubing (high-
temperature silicone rubber tubing soft, 1/16" ID, 1/8" OD, McMaster) connected 
the entrance port to the one direction syringe pump and the exit port to the waste 






4.3.5.2 Flow experiments   
The composites of flow chamber and tubing were sterilized separately by 
autoclave or 70% ethanol immersion or UV exposure overnight. The sterilized 
plastic slide was coated with 0.1% gelatin for more than 4 hours, and then dried 
in the air. NanogR cells were then seeded into the slide at density of 5000 
cells/cm2 in LIF free Dox free ESC media and then incubated at 37°C in a 5% 
CO2 atmosphere humidified incubator overnight. Prior to the experiment, the flow 
chamber was assembled and connected to a syringe pump with tubing filled with 
proper medium, the output ports were connected to waste container.  For dye 
separation experiments, cells were subjected to continuous flow of medium with 
2µM Calcein-AM for 30- 60minutes, then 10-30minutes continuous flow of 
complete medium.  
 
4.3.6 Mathematical Model 
4.3.6.1 Velocity and shear stress profiles 
The chamber geometry permits the wall shear stress acting at the chamber wall 
to be calculated as a function of the laminar flow rate, which is in turn controlled 
by a mechanical single-pass syringe pump and fluid viscosity.  







τ =      (1) 











     (2) 
where µ, ρ are the viscosity, density of the fluid; Q is flow rate; w and h are the 





length L in a channel of height h can be estimated from the relation (Atkinson 





= +     (3) 
 
4.3.6.2 Computational scheme 
Computational fluid model was used to simulate the concentration and velocity 
profiles using the finite element method (COMSOL Multiphysics v3.2, Burlington, 
MA). The concentration gradient generation driven by the syringe pump was 
based on the following three equations, including the 3D incompressible Navier–
Stokes equations: 
           (4) 
 
    ∇u = 0     (5) 
And the convection-diffusion transport equation 
        (6) 
 
where ρ, u, and p are the density, flow velocity and pressure of the liquid, and C 
and D are the concentration and diffusivity of the molecules in the liquid. At each 
time step, the flow velocity was first obtained, independently of the concentration, 
which was then calculated based on fluid flow field. The boundary conditions 
were as follows: specified flow velocity qt the inlet, zero normal stress at the 





equation, a constant concentration was set at the channel inlet. No-flux 
conditions were imposed at all channel walls.  
 
4.3.7 Image analysis 
Sequential images were acquired with a phase-inverted microscope (Olympus 
IX81), stored, assembled, and analyzed digitally by Photoshop CS4 program 
(Adobe). For the quantitative analysis of immune-fluorescent staining, the 
assembled color images were converted to black-white images. The integrated 
staining intensity was quantified with Matlab R2007 program (Matlab, Natick, MA) 
by normalized sum) of segmented image (0.5mm) intensity moving lengthwise 
along the y axis (the width) of the chamber images. 
   
4.3.8 Statistics/Data Analysis 
Experimental results were expressed as mean ± standard deviation (SD) . All the 
collected data were analyzed by ANOVA for multiple comparisons, and statistical 
significance was accepted at P<0.05. 
 
4.4 Results 
4.4.1 Regulation of Nanog expression and embryonic pluripotency in genetically 
modified embryonic stem cells in static culture 
We first characterized the Dox dependent Nanog expression and embryonic 
stem cell differentiation in varied static culture conditions, with a series of Dox 





Supplemental Figure 4.2, 4.3, 4.4). The NanogR cells grown in static culture 
were shown to have secretion of exogenous Nanog, when Dox concentration in 
medium was higher than 100ng/ml, while the endogenous Nanog was constantly 
suppressed (data not shown).  The amount of Nanog expression measured by 
immuno-fluorescence staining and RT-PCR was positively corelated to the 
concentration of Dox, and reached a maximum when Dox was 1000ng/ml.  
 
Dox induced Nanog expression, which in turn induced Dox concentration 
dependent early embryonic differentiation of NanogR cells, as shown by alkaline 
phosphatase (AP) analysis, Immunofluorescent staining of Oct 4 and RT-PCR 
analysis of varied pluripotency and early lineage differentiation markers. When 
cultured in mESC media supplemented with LIF, the Dox concentration mediated 
change of Nanog expression, did not induce specific differentiation (Figure 4.2, 







Figure 4.2  Titration of Dox concentration in NanogR cells (A) Immunofluorescent 
staining of NanogR cells at Day 3 (blue: DAPI; green: Nanog; red: Oct4).  (B) AP 
staining of the NanogR cells at Day 3. (C1-C4): RT-PCR measurement of Exogenous 
Nanog, Oct4, Gata4 and Fgf5 at Day3. *p<0.05. Scale bar: 100µm. 
 
The expression of the pluripotent marker Oct4 was sustained through the culture 
period, even when Nanog expression was suppressed by Dox removal. We 
observed decreases in Oct4 expression (by RT-PCR) and AP staining when Dox 
concentration was < 100ng/ml. Expression of endoderm/ectoderm/mesoderm 
differentiation markers was not detected (RT-PCR). These results suggested that 
the suppression of Nanog expression in culture media supplemented with LIF 





pluirpotent state. Therefore, downregulation of Nanog alone was not sufficient to 
induce cell differentiation.   
 
When LIF was removed from the ESC culture media (Figure 4.2, Supplemental 
Figure 4.3), we observed a decrease of AP (staining), and Oct4 expression (RT-
PCR) and increase of Fgf5 expression, suggesting early stage of ectoderm 
differentiation. No other differentiation markers were detected. When a stronger 
differentiation factor, RA, was added to the LIF-free ESC culture system, we 
observed further degree of differentiation, the loss of Oct4 expression and AP 
staining markers even with the presence of Nanog expression (Figure 4.2, 
Supplemental Figure 4.4). We also observed a significant increase of endoderm 
differentiation marker, Gata4, but no increase of Fgf5 associated with the 
decrease Dox concentration, suggesting RA suppression of early ectodermal 
differentiation, and enhancement of endodermal differentiation.  
 
In summary, static culture demonstrated the correlation between Dox 
concentration and Dox induced Nanog expression, and Nanog mediated 
embryonic differentiation under varied culture conditions. The NanogR cells had 
clear “cutoff” of Nanog expression and Nanog mediated differentiation at Dox 
concentration of 500ng/ml. Therefore, in flow experiments, we used bi-laminar 
flows of medium containing CDox=500ng/ml and CDox=0ng/ml to pattern 






4.4.2 Characterization of the fluidic chamber 
Using COMSOL Multiphysics®, the velocity profiles and concentration profiles in 
the flow chamber were analyzed in detail. The flow rates of 2 x 4µl/min 
corresponded to the Reynolds number Re=0.022 and the hydrodynamic 
development length of 48 µm in the fluidic chamber. Thus, the flow in each 
system may be considered as fully developed, with negligible variation in the 
direction transverse to the flow. The wall shear stress in the cell culture zone was 
2.8mPa for fluidic chamber, well under the values of shear stress of cells 
exposed to normal interstitial (Wang and Tarbell, 1995) or blood flow (Serls et al., 
2005). Simplified fluidic models were developed to study the simulated fluidic 
profiles and concentration profiles at steady state (Figure 4.1). Different 
concentration profiles of Dox, LIF, and RA were simulated, to show that the bi-
laminar-fluidic system permits the alignment of flows with different concentration 








Figure 4.3  AP staining of flow chamber at Day3 (A) Perfusion media: top, P (Dox: 
500µg/ml; LIF: 103units/ml); bottom, P. (B) Perfusion media: top, P; bottom, D1 (LIF: 
103units/ml). (C) Perfusion media: top, P; bottom, D2 (LIF free). (D) Perfusion media: top, 
P; bottom, D3 (LIF free, RA: 5µM). Flow direction: from left to right. Scale bar: 1mm 
(Left), 100µm (Right).  All the staining images were taken after 7 minutes incubation of 
alkaline dye mixture. 
 
4.4.3 Patterning of embryonic pluripotency 
In flow experiments, we generated patterned pluripotency (P) and differentiation 





were exposed to. In the control experiment (P: P), we aligned two pluripotency 
streams (P) containing Dox and LIF supplemented mESC media together 
(Figure 4.3A, Figure 4.4). Consistent with the characterization result of static 
culture, we observed uniform staining of AP, Nanog and Oct4 across the flow 
chambers. The flow did not significantly affect the expression Nanog and Oct4.     
 
 
Figure 4.4  Immunofluorescent staining of flow experiment (P: P) (A) Experiment 
model: cultured NanogR cells were exposed to laminar fluidic flows with two [P] streams. 
(B) Simulated Dox and LIF concentration profiles at the beginning of the flow chamber in 
steady status. (C) Normalized immunofluorescent Nanog / Oct4 staining intensity across 
the flow chamber in y direction, n=4. (D) Immunofluorescent staining of the flow 
chambers. Scale bar: 1mm. (E) Immunofluorescent staining of selected colonies in flow 
chamber. Scale bar: 100µm. (Green: Nanog; Red: Oct4, Blue: DAPI)  
 
We then aligned the pluripotency stream (P) containing Dox and LIF 
supplemented mESC media with differentiation stream1 (D1) containing only LIF 
supplemented mESC media, or differentiation stream 2 (D2) containing no Dox 





patterning Dox and LIF distribution across the flow chamber, we successfully 
developed patterned Nanog expression from the same population of cells 
cultured in the flow chamber. By AP staining and immune-fluorescent staining we 
did not see significant impact by modulation of LIF concentration across the flow 
chamber.  Both experiments exhibited patterned AP staining according to Dox 
concentration profiles within a short period of incubation (Figure 4.3B, 4.3C), 
suggesting different AP activities modulated by Dox concentration dependent 
Nanog expression. In both experiments, we observed patterned Nanog staining 
across the flow chambers (Figure 4.5, 4.6).   
 
By pooling different individual staining result, and quantifying the normalized 
intensity of Nanog / Oct4 staining in direction perpendicular to flow direction, we 
observed a gradual decrease in the Nanog staining across the pluripotency and 
differentiation interface, matching the simulated concentration profiles of Dox in 
each experiment (Figure 4.5B, 4.5C, 4.6B, 4.6C). We also observed relatively 
uniform expression of Oct4 across the pluripotency (P) and differentiation zones 
(D1, D2) in the flow chamber, suggesting that the suppression of Nanog 
expression, and removal of LIF were not sufficient to induce celldiff erentiation.  
Fluorescent images in higher magnitudes demonstrated the patterned Nanog 







Figure 4.5  Immunofluorescent staining of flow experiment (P: D1) (A) 
Experiment model: cultured NanogR cells were exposed to laminar fluidic flows with one 
stream of [P] in align with another stream of [D1]. (B) Simulated Dox and LIF 
concentration profiles at the beginning of the flow chamber in steady status. (C) 
Normalized immunofluorescent Nanog / Oct4 staining intensity across the flow chamber 
in y direction, n=5. (D) Immunofluorescent staining of the flow chambers. Scale bar: 
1mm. (E) Immunofluorescent staining of selected colonies in flow chamber. Scale bar: 








Figure 4.6  Immunofluorescent staining of flow experiment (P: D2) (A) 
Experiment model: cultured NanogR cells were exposed to laminar fluidic flows with one 
stream of [P] in align with another stream of [D2]. (B) Simulated Dox and LIF 
concentration profiles at the beginning of the flow chamber in steady status. (C) 
Normalized immunofluorescent Nanog / Oct4 staining intensity across the flow chamber 
in y direction, n=4. (D) Immunofluorescent staining of the flow chambers. Scale bar: 
1mm. (E) Immunofluorescent staining of selected colonies in flow chamber. Scale bar: 
100µm. (Green: Nanog; Red: Oct4, Blue: DAPI)  
 
 
In the last experimental group (P: D3), we aligned the pluirpotency stream (P) 
containing Dox and LIF supplemented mESC media with differentiation stream3 
(D3) containing no Dox and no LIF but RA supplemented mESC media within 
flow chamber.  The AP staining exhibited patterned staining intensity according 
the patterned P stream and D3 stream. However, we also observed a significant 





medium supplemented with Dox and LIF. This was probably caused by either 
diffusion of RA, or interaction with cell differentiation zone (Figure 4.3D).   
 
The immune-fluorescent staining and quantified staining intensity from individual 
experiment showed clear patterned Nanog staining as well as Oct4 staining 
across the pluripotency and differentiation interface, consistent with simulated 
concentration profiles of Dox, LIF and RA (Figure 4.7). The parallel DAPI 
staining showed that the differences in staining intensity of Nanog and Oct4 were 
not caused by uneven distribution of cell population.  Fluorescent images in 
higher magnitudes demonstrated the generation of patterned Nanog and Oct4 
expression within a single colony (Figure 4.7E, top), along with the gradual 
change of morphology from aggregated cell population with clear edge to a flatter 
and more diffusive cell population. Similar patterns of Nanog and Oct4 
expression and morphology was also observed at inter colonies level (Figure 
4.7E, bottom).  In summary, by using bi-laminar flow system, we successfully 
patterned zonal organization of Es cell pluripotency and differentiation by 
patterning Dox mediated Nanog expression, and concurrent application of LIF 






Figure 4.7  Immunofluorescent staining of flow experiment (P: D3) (A) 
Experiment model: cultured NanogR cells were exposed to laminar fluidic flows with one 
stream of [P] in align with another stream of [D3]. (B)  Simulated Dox, LIF and RA 
concentration profiles at the beginning of the flow chamber in steady status. (C) 
Normalized immunofluorescent Nanog / Oct4 staining intensity across the flow chamber 
in y direction, n=4. (D) Immunofluorescent staining of the flow chambers. Scale bar: 
1mm. (E) Immunofluorescent staining of selected colonies in flow chamber. Scale bar: 
100µm. (Green: Nanog; Red: Oct4, Blue: DAPI)  
 
4.5 Discussion 
We used a simple bi-laminar fluidic system to pattern stem cells pluripotency at 
transcriptional level, and to generate boundaries between different gene 
expression domains within the same cell population. The patterning of stem cells 
pluripotency was engineered by patterned distribution of the modulator of 
inducible Nanog expression vector, Dox, along with patterned delivery of LIF and 





patterned the Nanog expressing pluripotent zone in alignment with varied Nanog-
suppressed differentiation zones with increased strength of differentiation signals: 
D1, suppressed Nanog expression only; D2: suppressed Nanog expression and 
removal of pluripotency maintenance factor, LIF; D3: suppressed Nanog 
expression, removal of LIF and addition of differentiation factor, RA.   
 
Consistent with previous studies, we found the down-regulation of Nanog 
predisposed cells towards differentiation but did not necessary mark definitive 
commitment (Chamber et al., 2007). Only when the suppression of intrinsic 
Nanog expression met proper exogenous differentiation signals, as for example 
the removal of LIF and addition of RA, the signals consolidated into stem cell 
differentiation commitment. Using this strategy, from a single colony, we can 
observe the generation of pluripotency – differentiation boundaries with zonal 
organization of Nanog and Oct4 expression, as well as the gradual change of 
colony morphology, in which cells gradually changed their tightly packed 
adherent morphology to a more spread-out morphology.  
 
This strategy of patterning the expression of key master regulator genes within 
tissues mimics some mechanisms of the development that underlie patterned 
differentiation in which molecular signals and networks orchestrate the 
development. Cells instructed by these signals ultimately form the remarkable 
multicellular patterns and structures associated with development. In most cases, 





been correlated to a specific cellular fate or behavior and thus serve as markers 
of cell response. A major challenge is to elucidate the mechanistic relation 
between these molecular developmental markers and cell response.  This 
transcriptional patterning strategy may help develop future mechanistic models 
that predict not only the spatiotemporal evolution of developmental signals but 
also the cellular rearrangements and turnover as development progresses.  
 
This study results in a useful platform to study the boundaries between gene 
expression domains, which is central to the understanding of development.  
Within this system, non-lineage boundaries could be established, maintained or 
reiterated to mimic the natural development process, where cell can move across 
gene expression boundaries and adapt their fate to that of their local neighbors. 
This non-lineage boundary is common in development process; examples 
include the boundary between the wing and the notum in Drosophila melangaster 
(Mann and Morata, 2000), and in vertebrate embryos the boundaries between 
the foregut and hindgut (Tremblay and Zaret, 2005) and between the somites 
(Kulesa and Fraser, 2002; Dahmann et al., 2011; Alexander et al., 2009).  The 
system also allows short range cross talk between the boundaries, enabling the 
study of short range juxtacrine specification of cell fate, as well the study of long 
range induction by patterning specific gene expression or morphogen factors. In 
addition, the system could be used to analyze lineage boundaries, where the 






The fluidic chamber offers significant flexibility compared to other microfluidic 
systems.  It allows the cells to be attached to various substrates and to be micro-
patterned before the chamber assembly, which can provide better control of cell 
seeding and distribution, a feature suitable to a variety of cell culture applications.  
After the flow experiment, the substrates can be easily disassembled; samples at 
specific sites can be collected or fixed for variety of staining and molecular 
assays, providing more systematic analysis of the boundaries engineered.  
 
4.6 Conclusion 
In summary, we demonstrate that continuous, graded pluripotency-differentiation 
boundaries can be established by patterning the Nanog gene expression along 
with other exogenous signaling factors via a simple laminar-fluidic system. This 
approach provides an innovative model to pattern cellular function at 
transcriptional level, engineer boundaries of different gene expression domains, 





4.7  Supplemental Information 
Gene  Accesion Number  5’ Primer  3’Primer   

























































Supplemental Table 4.1  Table of oligos used for quantitative qPCR analysis 
 
 







Supplemental Figure 4.2  Titration of Dox concentration in NanogR cells in ESC 
media containing LIF (A) Immunofluorescent staining of NanogR cells at Day 1,3,5 
(blue: DAPI; green: Nanog; red: Oct4). (B) AP staining of the NanogR cells at Day 1,3,5. 
(C1-C4) RT-PCR measurement of exogenous Nanog, Oct4, Gata4 and Fgf5 at Day3. 






Supplemental Figure 4.3 Titration of Dox concentration in NanogR cells in ESC 
media containing no LIF (A) Immunofluorescent staining of NanogR cells at Day 1,3,5 
(blue: DAPI; green: Nanog; red: Oct4). (B) AP staining of the NanogR cells at Day 1,3,5. 
(C1-C4) RT-PCR measurement of exogenous Nanog, Oct4, Gata4 and Fgf5 at Day3. 






Supplemental Figure 4.4  Titration of Dox concentration in NanogR cells in ESC media 
containing no LIF but RA (A) Immunofluorescent staining of NanogR cells at Day 1,3,5 (blue: 
DAPI; green: Nanog; red: Oct4). (B) AP staining of the NanogR cells at Day 1,3,5. (C1-C4) RT-
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Chapter 5 Summary 
 
In this thesis, we introduced advanced genetic techniques into the tissue 
engineering and regeneration therapy. The central question we investigated is 
about the effect of regulation of gene expression in time and space on cell 
function. 
 
In the first project, in order to overcome the limited cell sources for cardiac tissue 
engineering and regeneration therapy, we developed a novel strategy for 
controlled expansion of non-proliferating primary neonatal rat cardiomyocytes by 
reversible immortalization. First, we were able to efficiently transfer 
immortalization genes: Tag / Bmi-1 / hTERT into cardiomyocytes by lentiviral 
vector mediated transduction.  
 
Second, we compared two immortalization strategies, TAg / Bmi-1 and hTERT; 
the TAg gene was more efficient in cell immortalization than the Bmi-1/hTERT 
gene, able to generate stabilized clones and efficiently expand cells within three 
weeks of culture, from very limit number of primary cells.  After expansion, we 
were able to completely remove the integrated immortalization gene by Cre-Loxp 
site recombinase reaction, and completely stop cell proliferation. Lastly, the 
reverted cell from reversible immortalization, exhibited partially rescued cardiac 
phenotypes and functions. For the first time, we demonstrated a reversible 





strategy for controlled expansion of primary cardiomyocytes could provide large 
amounts of the patient's own cardiomyocytes for cell therapy, and enable 
controlled in vitro study of cardiogenesis. 
 
In the future, we expect the convergence of reversible immortalization strategy 
and induced pluripotent stem (iPS) cell research. The application of reversible 
gene expression techniques would enable controlled pluripotency induction and 
reversion by removing the inserted genes. Standard clone selection, expansion 
and differentiation protocol would be developed across different cell sources. 
Most importantly, comprehensive epigenetic studies are needed to study how to 
completely recover specific cell phenotype from this process of reversible genetic 
modification.  
 
In the second project, we developed a novel strategy for patterning gene 
expression and thereby patterning the associated cell function, by using inducible 
gene expression systems and multi-laminar fluidic techniques. Using osteogenic 
differentiation of mouse mesenchymal stem cells as a model, we demonstrated 
spatial regulation of the expression of BMP-2 and BMP-2 mediated osteogenesis 
in a two-dimensional field of cultured cells, by flow patterning the modulator of 
inducible BMP-2 gene expression vector, Dox.  Compared with conventional 
methods of cell patterning, this strategy combinines inducible gene expression 
with laminar flow technologies and provides an innovative way to develop 





the developmental process in vivo. Therefore, the strategy could be used in 
engineering multi-phase tissue for regeneration therapy, or as a useful platform 
in studying interface / boundary formation in vitro. 
 
Based on the previous project, we were able to explore more sophisticated gene 
patterning for analysisperturbation in a spatial manner, which can assist the 
systems biology study of embryonic stem cell fate. In the third project, using 
Nanog safeguarded embryonic pluripotency as a model; we patterned Nanog 
gene expression, as well as soluble factors in the laminar fluidic system, thereby 
successfully developed varied differentiation – pluripotency boundaries between 
Nanog expressing pluripotency zones and Nanog suppressed early 
differentiation zones from the same population of cells, up to single colony scale. 
Based on this platform, system biologists are able to pick specific cells across 
these Nanog + / Nanog – boundaries, studying the penetration of single genetic 
perturbation, Nanog, in a spatial manner, which would help us to decipher the 
potential gene regulation network in spatial control of embryonic development. 
 
We believe that this unique gene patterning strategy can be further advanced in 
two major directions: 
 
The scientific direction: The combination of the gene patterning strategy with 
advanced cell patterning technologies, for studying cell interaction at boundaries 






The engineering direction:  In the thesis, as a ‘proof of concept’, patterned 
inducible gene expression was achieved in two-dimensional laminar fluidic 
systems.  We expect patterned inducible gene expression could also be realized 
in more complicated geometry or even 3 dimensional systems, when combing 
with varied patterning strategies, such as surface immobilization, spatially 
controlled release, as well as tissue printing techniques. The application of 
inducible / reversible genetic engineering combined with those patterning 
techniques, enables us to unlock the full biological potential to exhibit engineered 
function in controlled time and space, which holds promise for building fully 
biological tissues with structural and functional specification. 
 
In summary, we investigated cellular responses to temporal and spatial patterns 
of gene expression, by combining advanced genetic techniques with microfluidic 
platforms, towards better regulation of cell differentiation, formation of interfaces 







Micropatterned Mammalian Cells Exhibit Phenotype-Specific Left-Right 
Asymmetry 
 
Leo Q. Wan, Kacey Ronaldson, Miri Park, Grace Taylor, Yue Zhang, Jeffrey M. 
Gimble, Gordana Vunjak-Novakovic 
 
A.1 Abstract 
Left-right (LR) asymmetry (handedness, chirality) is a well-conserved biological 
property of critical importance to normal development. Changes in orientation of 
the LR axis due to genetic or environmental factors can lead to malformations 
and disease. While the LR asymmetry of organs and whole organisms has been 
extensively studied, little is known about the LR asymmetry at a cellular level. 
Here we show that the cultivation of cell populations on micropatterns with 
defined boundaries reveals intrinsic cell chirality that can be readily determined 
by image analysis of cell alignment and directional motion. By patterning 11 
different types of cells on several thousands of ring-shaped micropatterns of 
various sizes, we found that each cell type exhibited definite LR asymmetry (p 
value down to 10-185) that was different between normal and cancer cells of the 
same type, and not dependent on surface chemistry, protein coating, or the 
orientation of the gravitational field. Interestingly, drugs interfering with actin but 





results show that micropatterned cell populations exhibit phenotype-specific LR 
asymmetry that is dependent on the functionality of the actin cytoskeleton. We 
propose that micropatterning could potentially be used as an effective in vitro tool 
to study the initiation of LR asymmetry in cell populations, to diagnose disease 
and to study factors involved with birth defects in laterality. 
 
A.2 Introduction 
Left-right (LR) asymmetry is seen in the development of numerous living 
organisms, including climbing plants (1), helices of snail shells (2), and the 
human body (3, 4). Genetic diseases and prenatal exposure to teratogens can 
cause birth defects in laterality (5, 6). The LR asymmetry has been studied in 
animal embryos, which are difficult to control and are not necessarily 
representative of human condition (7, 8). Recent studies focused on directional 
nodal flow driven by primary cilia (9-11), pH gradients resulting from asymmetric 
expression of ion channels (12, 13), and asymmetric vesicular transport via 
myosin 1D along actin cable networks (14-16). 
 
The initiation of LR asymmetry in development is often first observed in 
populations of cells of the same type, such as snail embryonic cells at 4-cell and 
8-cell stages and mouse cells at embryonic nodes. The establishment of LR 
asymmetry or chirality within such cell clusters may rely on some intracellular 
structure, such as the hypothetical F-molecule or actin/microtubule cytoskeleton 





to predetermined dorsal-ventral and anterior-posterior axes. In addition, during 
development, the specification and self-organization of migrating cells are 
mediated by physical boundaries imposed by the extracellular matrix and the 
surrounding cells and tissues. We, therefore, hypothesized that the populations 
of cells of the same type, if cultured within patterns with well-defined boundaries, 
would express directional alignment and motion associated with the 
establishment of LR asymmetry. 
 
We find that the cells form an invariant chiral alignment, depending on the cell 
phenotype and actin function. We infer that all cells are intrinsically chiral and 
that the function of actin may play a significant role in switching the intrinsic 
chirality of cells and their LR asymmetry in developmental biology. Due to its 
simplicity, our 2D microscale system provides an effective method to study the 
LR symmetry of tissue development in vitro and may provide a useful tool for 
identifying biological and environmental factors involved in bilateral birth defects. 
 
A.3 Result and Discussion 
Cells exhibit distinct left-right asymmetry on micropatterned geometries  
We first cultured the C2C12 murine myoblasts on micropatterns with well-defined 
boundaries, such as circles, squares, linear strips, and rings (Figure A.S1) (19, 
20). Biased cell alignment was observed on linear strips and rings but not on 
circles and squares (Figure A.S2 a-f), suggesting the importance of appositional 





alignment was observed on linear strips and rings of different sizes (Figure A.S2 
g), rings with an inner diameter of 250 µm and a distance of 200 µm between the 
inner and outer boundary were used in subsequent studies. 
 
 
Figure A.1. Mouse myoblasts (C2C12) show distinct left-right asymmetry on 
micropatterned surfaces. Scale bars: 100 µm. (a) Asymmetric cell alignment on ring 
patterns (phase contrast image). (b) Cell alignment directions (green lines). (c) 
Thebiased angle of cell alignment (green lines) was defined as either CW or CCW, 
based on the deviation from the circumferential direction (blue dash line). (d) The 
circular histogram of biased angles shows CCW chirality. (e) Circumferential averages of 
the sub-regional biased angles at different radial positions on the ring (mean ± SEM). (f) 
The histogram of the mean biased angles of C2C12 cells (33 experiments, >1000 ring 
patterns). 
 
Phase contrast images, in which cell contour appears brighter than the inner cell 
region, were used to measure cell alignment (21) (Figure A.1a), as indicated by 
green lines in Figure 1b. Each green line was assigned a biased angle between -
90o and 90o, based on its deviation from the circumferential direction (blue dash 





negative value represented a clockwise (CW) alignment (Figure A.1c). An 
angular histogram (Figure 1d) and the radial distribution (Figure 1e) of the 
measured angles revealed preference for positive angles, corresponding to the 
CCW bias. In >30 independent series of experiments using >1000 individual 
rings (Table A.S2, Figure A.1f), the C2C12 cells showed CCW alignment with a 
biased angle of 8.47o  } 0.20o (mean ± SEM), with very strong statistical 
significance (p =9.3 ×10-186). 
 
Cell chirality on patterned surfaces depends on cell phenotype  
We then tested a panel of mouse, rat, and human cells derived from skeletal 
muscle, bone, adipose tissue, skin, heart, and blood vessels (Table A.S1). Cell 
phenotypes included myoblasts, osteoblasts, endothelial cells, fibroblasts, and 
mesenchymal stromal/stem cells. Interestingly, mouse (C2C12) and human 
skeletal muscle cells (hSkMCs) showed a CCW alignment, while all other cell 
types exhibited a CW alignment (Figure A.2). Cancer skin cells also exhibited a 
CCW alignment, different from the CCW alignment of skin fibroblasts from the 
same individual. These data suggest that adherent mammalian cells exhibit an 
invariant chirality determined by the cell phenotype and disease condition. 
 
Left-right asymmetry on micropatterns is established by mechanisms involving 







Figure A.2. Cell chirality on patterned substrates depends on cell phenotype and 
disease condition. (a) Phase contrast images of various cell types. (b) Cell source 
andtheir chirality on micropatterned surfaces. Here, “-” indicates that cells were isolated 
in the lab; CW: clockwise alignment; CCW: counter-clockwise alignment; N/S: not 
significantly biased to CW or CCW. The C2C12 cells and human skeletal muscle cells 
exhibit a counter-clockwise alignment while other cells that were studied show 
aclockwise alignment. The human skin cancer fibroblast cell line show a 









Figure A.3. Cellular Left-right asymmetry on micropatterned rings is established 
by mechanisms involving boundary effects. (a) Cells on a ring "sense" the z-axis 
throughattachment to the substrate and the x axis through the ring boundaries. The cell 
alignment bias of the y-axis (dash red lines) creates the observed cellular chiral behavior 
or LR asymmetry. (b) Centrosomes (bright green) are positioned closer to each 
boundary than nuclei (blue) in C2C12 cells (actin: red, tubulin: green). Scale bars: 50 µm. 
(c) Golgi apparatus (red) is positioned closer to ring boundaries than nuclei (blue) in 
hUVEC cells. Scale bars: 50 µm. (d) Phase contrast images of the cells (top) at 5, 10, 20, 
and 30 hours after cell seeding and the corresponding histograms (bottom) of biased 
angles from the sub-regions for each image. Scale bars: 100 µm. (e) The time history of 
the mean biased angle of C2C12 cells on a ring, with the insert for cell number 
increasing exponentially with time. (f) Average velocity and direction of C2C12 cells are 
indicated by arrowdirection and length, respectively. (g) Average velocity of C2C12 cell 
migration in the circumferential (Vθ) and the radial direction (Vr) as a function of radial 
position. (h) Average velocity and (i) the circumferential migration velocity of hUVEC 






For cells on a patterned geometry to display their chirality and to distinguish 
between left and right (y-axis), the polarity of the z-axis (up-down) and x-axis 
(front-back) must be established (Figure A.3a). Notably, the z-axis was 
established independent of gravity direction, as observed experimentally in 
vertically inverted cell cultures (Table A.S4). The geometric boundaries 
determined organelle positioning (i.e., x-axis), with centrosomes (bright green, 
Figure A.3b) and Golgi apparatus (red, Figure A.3c) being positioned closer to 
the boundaries than the cell nucleus (blue) (22), independent of the gravitational 
direction. In addition, cell chirality was maintained on patterns with different 
surface chemistry (23), and after the disruption of cadherin function (Figure A.S1, 
Table A.S5-6). 
 
For further insight into the biased cell alignment, we analyzed C2C12 cell motion 
(Video S1-2, not shown here). Cell alignment did not show a clear bias before 
confluency (Figure A.3d-e), suggesting that the inhibition of random walk 
through physical contact was necessary for the cells to exhibit chirality. The cells 
were labeled and tracked along the inner and outer ring pattern (Video S3, not 
shown here), and the cell migration velocity was estimated by digital image 
correlation (24). The speed of migration was higher at the inner and outer ring 
boundaries (~ 25 µm/hr in average) than within the interior region (~10 µm/hr). 
The average velocity (Figure A.3f) and the velocity changes in radial and 





the CW direction at the inner ring boundary (at 8µm/hr), and in the CCW direction 
at the outer ring boundary (at 4 µm/hr). 
 
At the level of an individual cell, this seemingly opposite circular motion of cells 
on the inner and outer boundary is in fact consistent with biased migration. 
Based on cell polarization at boundaries, the x-axis can be defined as the 
direction from the nucleus to centrosome (25), as shown in Figure A.3a. Cell 
migration can thus be considered as ‘leftward bias’ along both the inner and 
outer ring boundary. Also, cell alignment on micropatterns is related to the cell 
migration at the boundaries, as seen for a C2C12 cell migrating towards a 
boundary and adopting the leftward biased migration. Because cell polarization 
and biased migration occur at the boundaries of micropatterns, cell proximity to a 
boundary is necessary for the expression of chirality. This finding was further 
supported by the biased cell alignment being most clearly seen in the regions 
close to the boundaries, especially for less elongated cells such as cardiac 
fibroblasts (Figure A.2a). 
 
The mean biased angle of human umbilical cord endothelial cells (hUVEC) on 
rings was similar in magnitude to that of C2C12 cells, but was negative (-8.47o  } 
0.33o, n=388), indicating a CW alignment (Table A.S3). By the time the cell 
chirality was established (15-20 hours after seeding, Video S4-6), cells along the 
boundaries had a significantly higher migration speed (35 µm/hr) than those in 





in the CCW direction at the inner ring boundary (15µm/hr) and in the CW 
direction at the outer ring boundary (20 µm/hr) (Figure A.2h-i). Based on the x-
axis directed from the nucleus to the centrosome/Golgi apparatus, the migration 
of hUVECs exhibited a ‘rightward’ bias. 
 
Chirality of muscle cells requires functional actin but not tubulin 
To investigate the roles of actin and tubulin, cyoskeletal proteins putatively linked 
to cell chirality (1, 2, 14, 16, 25), we inhibited the dynamics of their polymerization 
and depolymerization (Figure A.4a-b). For C2C12 and hUVEC cells, cell 
alignment on micropatterned rings followed a dose-dependent response (Table 
A.S7). Low concentrations of the actin treadmilling inhibitors (Latrunculin A, 
cytochalsin D, Jasplakinolide) reversed the chirality of C2C12 cells from CCW 
into CW. In contrast, inhibitors of tubulin dynamics (Nocodazole, Taxol) at 
concentrations below those resulting in cell apoptosis did not change cell chirality. 
Similar results were obtained for human skeletal muscle cells. The CCW bias of 
the cells depended on the function of actin but not non-muscle myosin II (Figure 
A.S3). In contrast to C2C12 cells, the drugs tested could not reverse the chirality 
of hUVEC cells or rat cardiac fibroblasts. Collectively, these data suggest that 





Figure A.4. Chirality of muscle cells requires functional actin but not tubulin. (a) 
Phase contrast images and (b) chirality of C2C12 cells on micro-patterned rings in the 
presence of Latrunculin A, Cytochalasin D, Jasplakinolide, Nocodazole, and Taxol. 
Scalebars: 100 µm. (c) Latrunculin A does not change the polarity of C2C12 cells, as the 
cells positioned their centrosome (bright green), rather than the nucleus (blue), closer to 
ring boundaries. Scale bars: 50 µm. (d) Migration of C2C12 cells in the presence of 
Latrunculin A, with the direction and magnitude of velocity indicated by arrow direction 
and length, respectively. (e) Average velocity of the cells along the circumferential 
direction (Vθ) and the radial direction (Vr) as a function of radial position. 
 
Interestingly, C2C12 cells treated with Latrunculin A polarized in the same 
fashion as the untreated cells (Figure A.4c), as evidenced by organelle 
positioning relative to boundaries, suggesting that the drug did not alter cell 
polarization. Analysis of cell migration (Video S7-8, not shown here) showed 
reversal at the boundaries (Figure A.4d-e), with the cells migrating CW along the 
outer ring and CCW along the inner ring at 15 µm/hr. Thus, inhibition of actin 
function reversed the CCW chirality and the biased migration of C2C12 cells. 
 
It is possible that two competing mechanisms co-exist within cells to determine 





lead to the intrinsic ‘leftward’ bias at the boundaries and subsequent CCW 
alignment in chiral morphogenesis. The second mechanism would induce 
intrinsic ‘rightward’ bias at the boundaries and a CW alignment in chiral 
morphogenesis. The differences in chirality may be due to the higher expression 
of actin in muscle cells than other cells (26, 27), necessitating identification of 
cell-type-related determinants of chirality in tissue development. Interestingly, 
actin bundles were reported to account for cardiac looping, the first visible sign of 
LR asymmetry in vertebrate embryos (28, 29). While the exact mechanism 
detailing how actin affects cell chirality is still unknown, our drug treatment data 
show that the mammalian muscle cells share similarities in their chirality with 
invertebrate cells such as those in snail embryos (2). Further studies are 
necessary to evaluate the role of actin expression levels in the establishment and 
reversal of cell chirality, possibly mediated through the non-canonical Wnt 
signaling pathway which plays a critical role in pattern determination during 
embryonic development (30). 
 
In summary, cells cultured on micropatterns with well-defined appositional 
boundaries exhibit chiral morphogenesis that can be readily determined by 
analysis of cell alignment and directional motion. In studies of 11 different cell 
types that were countered on several thousand patterns, we observed that the 
cell chirality was defined by the cell phenotype, and that the loss of actin but not 
microtubule function could reverse the CCW cell chirality. The simple and highly 





study the initiation of chiral morphogenesis and identify genetic, biochemical and 
environmental factors leading to malformations. 
 
A.4 Methods 
Microcontact Printing   
Cell patterning was done by using olydimethylsiloxane (PDMS) elastomeric 
stamps and self-assembly monolayers (SAMs) (19, 20, 23). A master mold was 
first fabricated with SU-8 2050 photoresist (MicroChem Corp, Newton, MA) and 
chromium masks with desired geometric features. The mixture (10:1) of PDMS 
pre-polymer and curing agent (Dow Corning, Midland, MI) was poured into the 
mold and cured at 70°C for 4 hours. 
 
In most studies (and unless indicated otherwise), an adhesive SAM 
octadecanethiol (Sigma) was transferred onto the gold-coated (150 Å in 
thickness) glass slide with the PDMS stamp (Figure A.S1) (19). The slide was 
then immersed in a non-adhesive ethylene glycol-terminated SAM (HS-(CH2)11-
EG3, Prochimia, Poland) for 3 hours. Finally, patterned surfaces were washed 
with ethanol and coated with 10 µg/ml fibronectin (Sigma) for 30 minutes.  
 
Alternatively (Figure A. S1), the PDMS stamp was coated with 50 µg/ml 
fibronectin for 30 minutes, aspirated, and dried in the air for 1 minute (23). The 
stamp was then gently placed onto tissue culture-treated dishes for 2 minutes, 





glycol (PLL-g-PEG; Susos AG, Dübendorf, Switzerland), for 1 hour. Finally the 
surface was washed with phosphate buffered saline (PBS). 
 
Cell Culture 
Cells were maintained in tissue flasks with culture media specified in Table A.S1. 
After reaching 70% confluency, cells were trypsinized and seeded onto protein-
coated patterned surfaces. Once the cells attached, extra cells were washed off 
with fresh medium. At this time drugs were added into the culture medium if 
necessary. Phase contrast images were taken after overnight incubation at 37oC 
and 5% CO2 when cells reached confluency on the ring patterns. 
 
Drug Treatment  
To examine the role of actin in left-right (LR) asymmetry, cells were tested with 
20 - 500 nM Latrunculin A, 0.05 - 1.0 µg/ml Cytochalasin D, and 1 - 100 nM 
Jasplakinolide. Latrunculin A inhibits actin polymerization by forming a 1:1 molar 
complex with G-actin, thereby inhibiting its ability to polymerize into F-actin (31). 
Cytochalasin D inhibits actin polymerization by binding to the growing ends of F-
actin chains and thus preventing the attachment and addition of G-actin 
monomers (32). Jasplakinolide is known to bind to and stabilize actin filaments in 
vitro (33). 
 
To examine the role of microtubules in LR asymmetry, 0.2- 2 µM Nocodazole, 





by destabilizing and disassembling microtubules (32). Taxol inhibits the 
microtubule depolymerization and stabilizes microtubules (34). 
 
To examine the role of the actomyosin motor, cells were tested with 0.2 - 10 mM 
Y-27632, 1 - 20 mM ML-7, and 0.5 - 10 mM Blebbistatin. Y-27632 works as a 
selective inhibitor to prevent the phosphorylation of the myosin regulatory light 
chain (35). ML-7 acts as a selective inhibitor of the myosin light chain kinase (36). 
Blebbistatin forms a low actin affinity complex through binding to myosin heads, 
causing the inhibition of nonmuscle myosin II ATPase activity (37).  
 
Immunofluorescence Staining 
After imaging, cells were fixed with 4% formaldehyde in cytoskeletal buffer (10 
mM MES, 138 mM KCl, 3 mM MgCl2, 2 mM EGTA, and 0.32 M sucrose) for 25 
minutes. For actin / tubulin double staining, the cells were incubated with 
phalloidin-TRITC (1:400; Invitrogen) and anti-Tubulin-FITC (1:50; Sigma) for 1 
hour. For the Golgi apparatus positioning inside patterned rings, the cells were 
incubated in 1µg/ml anti-human golgin-97 (Invitrogen) for 1 hour. After secondary 
antibodies, cell nuclei were stained with 200 ng/ml 40, 6-diamidino-2-
phenylindole  (DAPI; Sigma) for 10 minutes. Finally, the cells were mounted with 
Fluoromount-G medium (SouthernBiotech, Birmingham, AL). 
 





High-resolution phase contrast images of live patterned cells were taken at a 
resolution of ~0.645 µm /pixel, and analyzed using a custom-written code in 
MatLab (MathWorks, Natick, MA), based on the automated detection of intensity 
gradient and circular statistics (21). In this algorithm, the intensity gradient was 
determined pixel by pixel with a Gaussian differential filter. In each sub-region of 
the image, the dominant local direction was determined using an accumulator 
scheme, in which the orientation of each pixel follows a von Mises distribution, a 
circular analogue of the linear normal distribution. Subsequently, the orientation 
in each sub-region was converted into an angle bias based on its deviation from 
the circumferential direction (see Figure A.1c). Mean angle and standard 
deviation of LR asymmetry were calculated for all sub-regions, using circular 
statistics (38). We verified that the variation of sub-region size from 10 by 10 
pixels to 60 by 60 pixels would not significantly alter the judgment of cell chirality 
on rings. The sub-region size was therefore set to 20 by 20 pixels (i.e., 13 by 13 
µm).  
 
Analysis of Cell Migration  
For time-lapse videos, cells were patterned on a gold-coated glass-bottom Petri 
dish (ibid, München, Germany). After cells attached, the dish was transferred into 
an environmental chamber (37oC and 5% CO2) and image time series were 
recorded every 5 minutes at a resolution of 1.56 µm/pixel for a total time of 20-40 
hours. As the image capture rate is much higher than the characteristic time for 





estimation, were used to determine the displacements of cell migration. A FFT 
(fast Fourier transform)- based method was first utilized to match regions of two 
sequential phase contrast images. The calculated displacement values were then 
used as inputs for a more accurate estimation of displacement fields at a sub-
pixel level, using a second-order image correlation algorithm described 
previously (24). To evaluate the bias of cell migration, the obtained velocity field 
was further projected in the circumferential (Vθ) and radial (Vr) direction. 
 
Statistical Analysis.  
Cell chirality on ring patterns (i.e., clockwise or counterclockwise alignment) was 
determined from calculated biased angles in local regions with one sample test 
for the mean angle, analogous to the one sample t-test in linear statistics (38). 
The overall biased behavior of the cells was tested based on the number of rings 
exhibiting either clockwise or counter clockwise alignment in the rank test, with 





A.5 Supplemental Information 
 
Figure A.S1. Micro-fabrication and micro-contact printing for cell patterning. A 
negative photoresist mold was made first by UV (ultraviolet) crosslinking through a mask 
containing desired micropatterning features. PDMS (polydimethylsiloxane) elastomeric 
stamps were then casted with prepolymers onto the mold. In most experiments (path 1), 
octadecanethiol, an adhesive self-assembly monolayer (SAM), was transferred via the 
PDMS stamp onto goldcoated glass slides, which were then sequentially subjected to a 
non-adhesive ethylene glycolterminated SAM HS-(CH2)11-EG3 and fibronectin. 
Alternatively (path 2), fibronectin was stamped onto tissue culture treated plastic, which 
was subsequently backfilled with poly-Llysine-polyethylene glycol and washed with PBS 










Figure A. S2. C2C12 cells grown on micro-patterned surfaces. (a-f) Cells on strip 
and ring geometries clearly demonstrate asymmetric alignment, while those residing on 
the circular and square patterns do not. (g) A schematic of the conformity in the biased 
cell alignment between cells on strips and cells on rings. Green lines indicate the 
direction of cell alignment, while blue and red lines represent the opposite boundaries of 
strips or rings. Ring geometry shows a consistent biased alignment regardless of 
whether the linear strip was bent upward or downward to create ring geometry, 






Figure A. S3. Effects of drugs blocking the actomyosin motor. Phase contrast 
images (a) and chirality data (b) of C2C12 cells under the treatment of drugs that affect 
the function of actomyosin motor. These drugs (Blebbistatin, ML-7, and Y-27632) did not 







Table A. S1 Compositions of cell culture media. DMEM: Dulbecco's Modified Eagle 
Medium; P/S: penicillin/streptomycin; and FBS: fetal bovine serum; C2C12: mouse 
skeletal muscle C2C12 cell line; hUVEC: human umbilical vein endothelial cells; 
NIH/3T3: mouse embryonic fibroblast cell line; hASC: human adipose-derived stem cells; 
hMSC: human bone marrow-derived mesenchymal stem cells; hSkMC: human skeletal 








Tables A.S2 The chirality of mouse myoblast cell line C2C12 on ring patterns. CW: 
clockwise alignment, CCW: counter-clockwise alignment, and N/S: not significantly 








Table A.S3 The chirality of human umbilical vein endothelial cells, hUVECs on ring 
patterns. CW: clockwise alignment, CCW: counter-clockwise alignment, and N/S: not 










Table A.S4-6. Effects of culture conditions on cell chirality. S4 (top): The cells 
retained their chirality under inverted culture (upside down) as compared to that at 
normal condition, suggesting that there is no effect of gravity. S5 (middle): Cell chirality 
did not alter with protein coating with fibronectin, Type I collagen, laminin and Matrigel. 
S6 (bottom): Cell chirality was also conserved at reduced cell-cell interactions under low 
calcium conditions (either following the addition of a calcium chelator, EGTA, or in 








Table A.S7. Effects of actin and tubulin blockers. Dose-dependent changes in the 
left-right asymmetry of cells on patterned surfaces to various drugs that interfere with the 
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